SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: automated matches (864)
(-)
Protein domain: automated matches (864)
(-)
Chicken (Gallus gallus) [TaxId: 9031] (13)
2W59A:349-451; A:452-566; B:349-451; B:452-566STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT
2YEZA:178-278; B:COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
2YF1  [entry was replaced by entry 5AD0 without any SCOP domain information]
2YF5  [entry was replaced by entry 4D0C without any SCOP domain information]
2YF6  [entry was replaced by entry 4D0B without any SCOP domain information]
3BEVB:11MER STRUCTURE OF AN MHC CLASS I MOLECULE FROM B21 CHICKENS ILLUSTRATE PROMISCUOUS PEPTIDE BINDING
3BEWB:; E:10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21
3DBXA:188-285STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID
3JVGA:181-277; B:181-277; C:; D:CRYSTAL STRUCTURE OF CHICKEN CD1-1
3O81A:; B:BETA2-MICROGLOBULIN FROM GALLUS GALLUS
3P73A:178-273; B:CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
3P77A:178-273; B:CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
4OUOA:-2-107; A:115-231ANTI-BLA G 1 SCFV
(-)
Chimpanzee (Pan troglodytes) [TaxId: 9598] (1)
3UC0L:2-108; M:2-108CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
(-)
Cow (Bos taurus) [TaxId: 9913] (4)
2XFXA:182-277CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA
4IIQC:1-95; C:292-385CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4K3DL:2-107; L:108-212; M:3-107; M:108-211CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
4K3EL:1-107; L:108-212; M:3-107; M:108-211CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
(-)
Cricetulus migratorius [TaxId: 10032] (5)
3LD8B:1-113; B:114-217STRUCTURE OF JMJD6 AND FAB FRAGMENTS
3LDBB:1-113; B:114-217STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
3MJ8A:1-107; A:108-211; L:1-107; L:108-211CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
3MJ9L:2-107; L:108-212CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
3R06A:1-107; A:108-213; C:1-107; C:108-213; E:1-107; E:108-213; L:1-107; L:108-213CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT
(-)
Ctenopharyngodon idella [TaxId: 7959] (1)
3GBLA:CRYSTAL STRUCTURE OF GRASS CARP BETA2-MICROGLOBULIN
(-)
Escherichia coli [TaxId: 562] (1)
3TYFA:1-114; B:3-118; C:1-114; D:3-118CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
(-)
Fruit fly (Drosophila melanogaster) [TaxId: 7227] (2)
2YD1A:34-130; A:131-229CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF DROSOPHILA RECEPTOR PROTEIN TYROSINE PHOSPHATASE DLAR
3PXJA:32-130; A:131-230; B:32-130; B:131-230; C:33-130; C:131-230; D:33-130; D:131-230TANDEM IG REPEATS OF DLAR
(-)
Human (Homo sapiens) [TaxId: 9606] (448)
1TZGL:1-106; M:1-106CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1U2HA:X-RAY STRUCTURE OF THE N-TERMINALLY TRUNCATED HUMAN APEP-1
1U6AL:1-107CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1WT5A:; B:THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528
1X9QA:14-124; A:153-2684M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (SCFV)
1YA5A:1-100; A:101-198; B:1-100; B:101-197CRYSTAL STRUCTURE OF THE TITIN DOMAINS Z1Z2 IN COMPLEX WITH TELETHONIN
1ZA6A:1-113; C:1-113; E:1-113; G:1-113THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSL:2-107FAB 2G12 + MAN4
1ZLUK:2-107; L:2-107FAB 2G12 + MAN5
1ZLVK:2-107; L:2-107FAB 2G12 + MAN7
1ZLWK:2-107; L:2-107FAB 2G12 + MAN8
1ZT4C:184-281THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE
2A38A:1-100; A:101-194; B:1-100; B:101-194; C:1-100; C:101-194CRYSTAL STRUCTURE OF THE N-TERMINUS OF TITIN
2A9ML:; M:STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM
2AJ3A:2-107; C:2-107; E:2-107CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
2AXHA:3-115; A:116-244; B:3-115; B:116-244CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2AXJA:3-115; A:116-244; B:3-115; B:116-244CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2BNUA:2-115STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDFA:3-115; A:116-193; B:2-116; B:117-245STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
2CDGA:10-115; B:3-117; B:118-246STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2CMRL:1-106ACRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
2D3VA:3-94; A:95-195CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR A5 (LILRA5/LIR9/ILT11)
2D7TH:CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
2D9CA:SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN OF SIGNAL-REGULATORY PROTEIN BETA-1 (SIRP-BETA-1)
2DL9A:SOLUTION STRUCTURE OF THE IG-LIKE DOMAIN OF HUMAN LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4
2DM2A:SOLUTION STRUCTURE OF THE FIRST IG DOMAIN OF HUMAN PALLADIN
2DM3A:SOLUTION STRUCTURE OF THE SECOND IG DOMAIN OF HUMAN PALLADIN
2EDFA:SOLUTION STRUCTURE OF THE SECOND IG-LIKE DOMAIN(2826-2915) FROM HUMAN OBSCURIN
2EDJA:SOLUTION STRUCTURE OF THE FIFTH IG-LIKE DOMAIN FROM HUMAN ROUNDABOUT HOMOLOG 2
2EDKA:SOLUTION STRUCTURE OF THE THIRD IG-LIKE DOMAIN FROM HUMAN MYOSIN-BINDING PROTEIN C, FAST-TYPE
2EDNA:SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN FROM HUMAN MYOSIN-BINDING PROTEIN C, FAST-TYPE
2EIZB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX
2EKSB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX
2ENYA:SOLUTION STRUCTURE OF THE IG-LIKE DOMAIN (2735-2825) OF HUMAN OBSCURIN
2EO1A:SOLUTION STRUCTURE OF THE IG DOMAIN OF HUMAN OBSCN PROTEIN
2EYRA:1-117; B:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYSA:1-117; B:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYTA:1-117; B:3-119; C:1-117; D:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2F8VA:2-100; A:101-195; B:1-100; B:101-197; C:4-100; C:101-194; D:2-100; D:101-194STRUCTURE OF FULL LENGTH TELETHONIN IN COMPLEX WITH THE N-TERMINUS OF TITIN
2FJFA:1-107; C:1-107; E:1-107; G:1-107; J:1-107; L:1-107; M:1-107; O:1-107; Q:1-107; S:1-107; U:1-107; W:1-107STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGA:1-107; L:1-107STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHA:1-106; L:1-106STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FL5A:1-106; A:107-212; C:1-106; C:107-212; E:1-106; E:107-212; L:1-106; L:107-212COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2GI7A:2-88; A:89-183; B:0-88; B:89-183CRYSTAL STRUCTURE OF HUMAN PLATELET GLYCOPROTEIN VI (GPVI)
2GW5A:3-97CRYSTAL STRUCTURE OF LIR-2 (ILT4) AT 1.8 : DIFFERENCES FROM LIR-1 (ILT2) IN REGIONS IMPLICATED IN THE BINDING OF THE CYTOMEGALOVIRUS CLASS I MHC HOMOLOG UL18
2H32A:CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
2H9GA:1-107; L:1-107CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFA:2-106A; L:1-106ACRYSTAL STRUCTURE OF CB2 FAB
2HFGL:1-106ACRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2IALA:1-109; B:2-112; C:1-109; D:2-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAMC:1-109; D:2-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAND:1-109; E:3-112; I:1-109; J:2-112; N:1-109; O:3-112; S:1-109; T:3-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2J6EM:1-108CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2JB5L:3-112FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6A:3-112; L:4-112FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2JJSA:; B:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJTA:; B:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJUA:; B:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA
2JJVA:; B:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA(2)
2JJWA:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) GAMMA
2KDGA:SOLUTION STRUCTURE OF THE 1ST IG DOMAIN OF MYOTILIN
2KKQA:SOLUTION NMR STRUCTURE OF THE IG-LIKE C2-TYPE 2 DOMAIN OF HUMAN MYOTILIN. NORTHEAST STRUCTURAL GENOMICS TARGET HR3158.
2NMSA:THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
2NTSP:3-118CRYSTAL STRUCTURE OF SEK-HVB5.1
2NW2A:1-117; B:1-118; B:119-247CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2NYYC:1-111CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2OLDA:1-112; B:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM
2OM5A:4-99; A:100-204; A:205-295; A:296-384N-TERMINAL FRAGMENT OF HUMAN TAX1
2OMBA:1-112; B:1-112; C:1-112; D:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM
2OMNA:1-112; B:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P4(3)2(1)2 CRYSTAL FORM
2OTPA:3-95; B:3-95CRYSTAL STRUCTURE OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 1 (ILT1/LIR7/LILRA2)
2OZ4A:283-366; A:186-282; A:367-450STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2PYFA:1-115CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2Q87A:; B:; C:THE CRYSTAL STRUCTURE OF THE HUMAN IRP60 ECTODOMAIN
2QQKL:1-107NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQLL:1-106NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQNL:1-107NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2R56L:1-107; M:1-107CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2UV3A:; B:STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN (SIRP) ALPHA DOMAIN THAT BINDS CD47.
2V9TA:COMPLEX BETWEEN THE SECOND LRR DOMAIN OF SLIT2 AND THE FIRST IG DOMAIN FROM ROBO1
2VLMD:3-112; E:5-115; E:116-244THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VXQL:1-107CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2VXSL:1-108; M:1-108; N:1-108; O:2-108STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY
2VXVL:1-107CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2WBJA:82-180; C:8-113; E:82-180; G:10-113TCR COMPLEX
2WP3T:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX
2WQRA:228-330; A:331-438; A:439-545; B:225-330; B:331-438; B:439-546THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC
2WUBL:1-107; Q:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2WUCL:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2WWKT:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG F17R MUTANT COMPLEX
2WWMD:; T:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX IN SPACE GROUP P1
2XA8L:1-111CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2XNAA:2-111; B:3-115; B:116-243CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
2XQBL:5-107CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
2XTJD:THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
2XWTB:2-107CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2XY1A:207-300; A:301-398CRYSTAL STRUCTURE OF NCAM2 IG3-4
2XY2A:19-113; A:114-207CRYSTAL STRUCTURE OF NCAM2 IG1-2
2XZAL:1-109CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2XZCL:1-109CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2Y9RT:CRYSTAL STRUCTURE OF THE M10 DOMAIN OF TITIN
2YBRB:; E:; H:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YC1B:; E:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YD3A:29-123; A:124-228CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
2YD5A:30-124; A:125-228CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR
2YD8A:30-124; A:125-227CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR IN COMPLEX WITH SUCROSE OCTASULPHATE
2YK1L:4-107STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
2YKLL:4-107STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
2YR3A:SOLUTION STRUCTURE OF THE FOURTH IG-LIKE DOMAIN FROM MYOSIN LIGHT CHAIN KINASE, SMOOTH MUSCLE
2YSSB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX
2YUVA:SOLUTION STRUCTURE OF 2ND IMMUNOGLOBULIN DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
2YXMA:CRYSTAL STRUCTURE OF I-SET DOMAIN OF HUMAN MYOSIN BINDING PROTEINC
2ZNWA:1-106; A:124-236; B:1-106; B:124-236CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
2ZNXA:1-106; A:124-236; B:1-106; B:124-2365-FLUOROTRYPTOPHAN INCORPORATED SCFV10 COMPLEXED TO HEN EGG LYSOZYME
3AAZB:1-112; B:113-229; L:1-112; L:113-228CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3AUVA:12-117; A:135-253; B:11-117; B:135-252; C:11-117; C:135-252; D:11-118; D:135-253; E:11-117; E:135-252; F:11-117; F:136-252PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
3B2UD:1-107; D:108-213; G:1-107; G:108-213; K:1-107; K:108-213; L:1-107; L:108-213; O:1-107; O:108-213; R:1-107; R:108-213; U:1-107; U:108-213; X:1-107; X:108-213CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3BDYL:1-107DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BE1L:1-107DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3BJ91:CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
3BN3B:1-87; B:88-196CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
3BN9C:1-107; E:1-107CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3BW9A:182-276CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12-MER PEPTIDE FROM THE PP65 PROTEIN
3BWAA:182-276CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8-MER PEPTIDE FROM THE PP65 PROTEIN
3C08L:4-106CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3D85A:1-107CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3DGGA:1-110; C:1-110CRYSTAL STRUCTURE OF FABOX108
3DIFA:1-107; C:1-107CRYSTAL STRUCTURE OF FABOX117
3DX9B:2-129; D:2-129CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EO9L:1-107CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
3EOAA:1-107; L:1-107CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I
3EYOA:1-108; C:1-108CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3FN0L:3-107; L:108-211CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41
3FZUD:1-107; L:1-107IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3G04A:1-107; A:108-208CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID-STIMULATING AUTOANTIBODY
3G6AA:1-108; L:1-108CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3G6JE:1-106; G:1-106C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3GBML:3-105; M:3-106ACRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3GBNL:3-106ACRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ
3GIZL:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB
3GJEA:1-110; L:1-110RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GKWL:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3GRWA:150-247; A:248-355; L:1-107FGFR3 IN COMPLEX WITH A FAB
3GSNA:2-111CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3H0TA:1-111HEPCIDIN-FAB COMPLEX
3H3PH:; I:; L:; M:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3HC0B:1-107; L:1-107BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3HC3L:1-107BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HC4L:1-107BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HI1A:1-107; L:1-107STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING-SITE ANTIBODY F105
3HI5L:1-106CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3HI6L:2-106; Y:2-106CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3HMWL:1-106CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3HMXL:1-106CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3HUJE:1-117; F:2-118; G:1-117; H:1-118CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3IDXL:1-107CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
3INUL:1-107; N:1-107CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3JUYA:1-125; A:143-249; B:1-125; B:143-250; C:1-125; C:143-250; D:1-125; D:143-249; E:1-125; E:143-249; F:1-125; F:143-249CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3JWDL:1-107; O:1-107STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3K2UL:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3KDMA:3-111; A:112-218; L:3-111; L:112-218CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE
3KNBA:CRYSTAL STRUCTURE OF THE TITIN C-TERMINUS IN COMPLEX WITH OBSCURIN-LIKE 1
3KR3L:1-108CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
3KVQA:CRYSTAL STRUCTURE OF VEGFR2 EXTRACELLULAR DOMAIN D7
3KYMA:1-107; C:1-107; E:1-107; G:1-107; I:1-107; K:1-107; M:1-107; O:1-107CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3L5XL:1-107CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3L7FA:1-107; D:1-107; L:1-107STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836
3LH2H:; I:; J:; K:; L:; M:; N:; O:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
3LHPH:; I:; L:; M:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
3LMJL:1-112STRUCTURE OF HUMAN ANTI HIV 21C FAB
3LRSB:3-107; D:3-107; F:3-107; L:3-107STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3LZFL:2-107CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3M8OH:1-118; H:119-221; L:1-112HUMAN IGA1 FAB FRAGMENT
3MA9L:2-109; L:110-210CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
3MACL:2-109; L:110-211CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
3MFFA:11-121; B:2-115; C:11-121; D:2-1151F1E8HU TCR
3MFGB:CRYSTAL STRUCTURE OF TOXIC SHOCK SYNDROME TOXIN 1 (TSST-1) IN COMPLEX WITH THE HUMAN T CELL RECEPTOR BETA CHAIN VBETA2.1 (EP-8)
3MLRL:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
3MLSL:1-111; M:1-111; N:1-111; O:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV-1 GP120 V3 MIMOTOPE
3MLTA:1-111; D:1-111; G:1-111; L:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3MLUL:2-112CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
3MLVL:2-112; M:1-112CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3MLXL:2-108; M:2-108CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3MLYL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3MLZL:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
3MUGA:2-107; C:2-107; E:3-107; G:2-107; I:1-107; K:3-107CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3MUHL:2-107CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3MXWL:1-107CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3N9GL:1-111CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI-WEST NILE VIRUS MAB CR4354
3NA9L:1-107CRYSTAL STRUCTURE OF FAB15
3NAAL:1-107CRYSTAL STRUCTURE OF FAB15 MUT5
3NABL:1-107CRYSTAL STRUCTURE OF FAB15 MUT6
3NACL:1-107CRYSTAL STRUCTURE OF FAB15 MUT7
3NCJL:1-107CRYSTAL STRUCTURE OF FAB15 MUT8
3NFPB:1-106; L:1-106CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3NFSL:1-106CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3NGBC:1-107; C:108-216; F:3-107; F:108-216; K:1-107; K:108-216; L:3-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
3NH7L:2-109; L:110-211; M:2-109; M:110-211; N:2-109; N:110-211; O:2-109; O:110-211CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
3NPSC:3-106ACRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3NTCL:1-107; L:108-213CRYSTAL STRUCTURE OF KD-247 FAB, AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
3NZHL:1-107CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
3O4LD:7-111; E:2-117; E:118-246GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3O6FC:1-110; D:1-115; G:1-110; H:1-115CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3OAYK:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OAZK:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OB0K:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OF6A:2-119; B:2-119; C:1-119HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3OJ2C:251-359; D:251-359CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
3OJMB:251-361CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING P253R APERT MUTATION
3OJVC:147-249; C:250-359; D:147-249; D:250-359CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC'-BETAE LOOP
3OMZA:11-116; C:139-250; E:13-116; A:139-250; C:11-116CRYSTAL STRUCTURE OF MICA-SPECIFIC HUMAN GAMMA DELTA T CELL RECEPTOR
3OV6A:1000-1093; A:185-280CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE)
3P0VL:1-107; M:1-107ANTI-EGFR/HER3 FAB DL11 ALONE
3P0YL:1-107ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3P2TA:2-96; A:97-195CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR-5/CD85K)
3PGFL:1-107CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3PL6A:82-180; C:2-113STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3PUCA:ATOMIC RESOLUTION STRUCTURE OF TITIN DOMAIN M7
3PWPE:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3Q1SL:3-107; L:108-211HIV-1 NEUTRALIZING ANTIBODY Z13E1 IN COMPLEX WITH EPITOPE DISPLAY PROTEIN
3Q5OA:; B:CRYSTAL STRUCTURE OF HUMAN TITIN DOMAIN M10
3QCTL:108-213CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
3QCUL:108-213; M:108-213CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3QCVL:108-213; M:108-213CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3QDGE:4-117THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJE:4-117THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMD:2-109; E:2-115THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEHB:1-106; D:1-106; F:1-106; H:2-106CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEQD:2-109; E:1-114; E:115-243THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEUB:4-117; E:3-117THE CRYSTAL STRUCTURE OF TCR DMF5
3QFJE:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QH3B:1-116; D:1-116THE CRYSTAL STRUCTURE OF TCR A6
3QHFL:1-107CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
3QHZL:2-107; M:4-107CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3QIBC:2-111CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QNXA:1-112; B:3-118; B:119-221ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QNYA:2-112; B:3-118; B:119-221; C:1-112; D:4-118; D:119-221MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QO1A:1-112MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3QOS  [entry was replaced by entry 5I1D without any SCOP domain information]
3QOT  [entry was replaced by entry 5I18 without any SCOP domain information]
3QPQC:1-107; E:1-107; I:1-107; L:1-107CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3QPXL:1-106CRYSTAL STRUCTURE OF FAB C2507
3QQ9C:1-111; L:1-111CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3QRGL:1-111CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3R1GL:1-107STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3REVA:3-117CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RPIB:3-96; L:3-96CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY
3S6CA:1001-1093; A:177-277STRUCTURE OF HUMAN CD1E
3S97C:133-237; D:133-237; D:238-329PTPRZ CNTN1 COMPLEX
3SDXA:184-280; C:184-277; E:1-114; F:2-118; F:119-247; G:1-114; H:1-118; H:119-247CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SE8L:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
3SE9L:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG04 IN COMPLEX WITH HIV-1 GP120
3SKJL:1-107; M:1-107STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3SKNA:2-124; B:3-126; C:2-124; D:3-126; E:2-124; F:3-126; G:2-124; H:3-126CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3SM5  [entry was replaced by entry 5UGY without any SCOP domain information]
3SOBL:1-107; L:108-213THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
3SQOL:2-107; L:108-214PCSK9 J16 FAB COMPLEX
3T0VA:UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL
3T0WA:; B:FLUOROGEN ACTIVATING PROTEIN M8VL IN COMPLEX WITH DIMETHYLINDOLE RED
3T0XA:; B:FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED
3T2NL:1-108; M:1-108HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3TCLB:1-107; L:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3THML:1-111CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3TJEL:1-111CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
3TNMB:4-107; L:4-107CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3TNNB:4-108; D:4-108; F:4-108; L:4-108CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3TO4C:1-117; D:3-121STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TV3L:3-107CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
3TWCL:3-107CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
3TZVA:1-114; B:2-118; B:119-246; C:184-278; G:1-114; H:2-118; H:119-246CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U1SL:2-107; L:108-213CRYSTAL STRUCTURE OF HUMAN FAB PGT145, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3U2SB:2-107; L:2-107CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
3U30B:1-107; E:1-107CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3U46B:1-107; L:1-107CH04H/CH02L P212121
3U4BL:1-107CH04H/CH02L FAB P4
3U4EB:2-107; L:1-107CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3U6RA:; B:; H:; L:THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7
3U7WL:1-105; L:106-214CRYSTAL STRUCTURE OF NIH45-46 FAB
3U7YL:3-101; L:102-210STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
3UTPD:2-112; E:1-117; K:2-112; L:1-1171E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
3UX9B:4-111; B:136-254; D:4-111; D:136-255STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS
3VWJA:184-278; C:1-117; D:3-118; D:119-246TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKC:2-117; D:3-118TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
3VXQA:1-113; B:2-114; B:115-243; D:1-113; E:2-114; E:115-243H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3VXTA:2-111; B:1-112; B:113-241; C:2-111; D:1-112; D:113-241T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3W9DB:1-107; D:1-107STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3W9EB:1-107STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
3WD5L:1-106CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3WJJA:233-341; A:342-444; B:238-341; B:342-443CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB
3WJLA:232-341; A:342-443; B:237-341; B:342-444CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB
3ZL4L:3-110ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
3ZTNL:1-106STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ.
4ACPA:238-341; A:342-444; B:237-341; B:342-444DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
4AENA:84-180HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4AH2A:84-180HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION
4AIZA:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3
4AL8L:1-107STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4BM7A:237-341; A:342-443; B:238-341; B:342-445CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
4BSVA:236-341; A:342-445; B:236-341; B:342-445HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
4BSWA:236-341; A:342-445; B:236-341; B:342-445HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
4BYHA:238-341; A:342-444; B:236-341; B:342-444CRYSTAL STRUCTURE OF SIALYLATED IGG FC
4CMMA:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA V1
4D9LL:1-108; M:1-108; N:1-108; O:1-108FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4D9QD:1-107; L:1-107INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4D9RD:1-107; L:1-107INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4DEPB:7-104; B:105-207; B:208-310; E:6-104; E:105-207; E:208-314STRUCTURE OF THE IL-1B SIGNALING COMPLEX
4DKFL:1-106; M:1-106CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4DQOL:1-107CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4DTGL:1-111HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4DZBA:1-110; B:2-117MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2
4E41D:1-110; E:1-110; I:1-110; J:1-110STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4E42A:1-110; B:2-110; C:1-110; D:2-110STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4EDWL:1-107NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4EN3A:8-113; B:2-117CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4EOWL:2-111CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4ERSL:1-106A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
4EVNB:3-112; D:3-112; F:3-112; H:3-112; J:3-112; L:3-112; N:3-112; P:3-112CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE-REVERTED LIGHT CHAIN)
4EZMA:335-436; A:437-545; B:336-436; B:437-545; C:336-436; C:437-545; D:335-436; D:437-541; E:335-436; E:437-540; F:335-436; F:437-542CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23
4F57L:1-108FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4F58L:1-108; M:1-108; N:1-108; O:1-108FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4FNLL:1-106; M:1-106CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4FP8L:1-106; M:1-106; N:1-106; O:1-106CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4FQ1L:9-108; L:109-209CRYSTAL STRUCTURE OF PGT121 FAB
4FQ2L:8-108CRYSTAL STRUCTURE OF 10-1074 FAB
4FQCL:10-108; L:109-209CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N-GLYCAN
4FQHB:2-107; L:2-107CRYSTAL STRUCTURE OF FAB CR9114
4FQIL:2-107CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4FQJL:1-107INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4FQXA:82-181CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
4FZ8L:1-107CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4FZEL:2-107CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4G3YL:1-107CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4G7VL:1-107CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)
4G7YL:1-107CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)
4G8EA:1-127; B:3-134CRYSTAL STRUCTURE OF CLONE18 TCR
4G8FA:3-128; B:1-127CRYSTAL STRUCTURE OF CLONE42 TCR
4GRLC:2-113CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4GRMB:3-117; D:1-117THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4GSDL:5-108H5.3 FAB STRUCTURE
4GW4B:4-96; L:4-96CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4GXVL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4H8WL:3-108CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4HAFA:236-341; A:342-444; B:239-341; B:342-444CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)
4HBQA:1-90; B:1-90CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2
4HC1A:9-90; B:9-90CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4HCRA:1-90; B:1-90; L:1-111; N:1-111CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
4HD9A:1-90CRYSTAL STRUCTURE OF NATIVE HUMAN MADCAM-1 D1D2 DOMAIN
4HF5L:3-107CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFUL:1-106CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFWA:2-106; L:1-106ANTI ROTAVIRUS ANTIBODY
4HH9A:1-107; C:1-107ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4HIEA:2-107; A:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
4HIHA:2-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
4HIIA:2-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE-GALACTOSE
4HIJA:5-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE-(1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
4HJGA:1-107MEDITOPE-ENABLED TRASTUZUMAB
4HJJL:1-113; L:114-228; L:229-327STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
4HK0B:1-109; D:1-109UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HK3N:1-109I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HKXB:1-109INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
4HKZA:1-107TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4HQQL:1-107CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4HWBL:1-104; L:105-212CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4I2XA:1-107; C:1-107CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
4I3RL:1-106CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4I3SL:1-107CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4I77L:1-107LEBRIKIZUMAB FAB BOUND TO IL-13
4IIQA:2-110; B:2-116CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4IMKC:3-109; C:110-215; D:3-109; D:110-212UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2
4IOIA:1-107MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4J4PD:19-130; L:19-130THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4J6RL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
4JAMB:3-107; L:2-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
4JANB:2-105; L:2-105CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4JB9L:1-102CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4JFHE:1-116HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JFXA:1-107; L:1-107STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4JFYA:1-107; L:1-107APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
4JFZL:1-107STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG0L:1-107STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG1L:1-107STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
4JHAL:1-107CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4JKPL:3-101; L:102-209RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI-HIV-1 ANTIBODIES
4JKWA:STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH ISOPENTENYL PYROPHOSPHATE (IPP)
4JM2B:1-106CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4JM4L:1-107CRYSTAL STRUCTURE OF PGT 135 FAB
4JPIB:2-109; L:2-109CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPKL:1-109CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPVL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4JPWL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4JY4A:9-108; A:109-211CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4JY5L:8-108CRYSTAL STRUCTURE OF HUMAN FAB PGT122, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4JY6A:8-111; A:112-213; C:8-108; C:109-210CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4K55A:STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE (HMBPP)
4K7PX:1-107GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4K94L:3-108; L:109-212CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODY FAB19
4KHTL:2-109; L:110-210TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
4KHXL:2-109; L:110-208CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062
4KJYB:; D:COMPLEX OF HIGH-AFFINITY SIRP ALPHA VARIANT FD6 WITH CD47
4KMTL:1-107CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4KQ3L:1-106CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4KU1A:237-341; A:342-443; B:237-341; B:342-444ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
4KVNL:2-106CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
4KY1L:1-107HUMANIZED HP1/2 FAB
4L4JA:237-341; A:342-444; B:239-341; B:342-444CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
4L4TA:179-269; C:179-269; D:1-110; E:2-116; E:117-244; G:1-110; H:3-116; H:117-244STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VA:179-269; E:117-244; G:1-110; H:3-116; H:117-242; C:179-269; D:1-110; E:2-116STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4L8SA:3-110; B:2-115; B:116-243CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4LCWA:179-269; C:179-269; D:1-110; E:2-116; E:117-244; G:1-110; H:3-116; H:117-242THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LFHD:5-120; D:121-206; G:10-125CRYSTAL STRUCTURE OF 9C2 TCR
4LHUA:184-277; D:5-120; D:121-206; G:10-125CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4LKCA:2-108AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4LL9A:2-100; A:101-197; B:2-100; B:101-197; C:2-100; C:101-197CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB1 MOLECULE
4LLAA:4-99; A:100-201; B:4-99; B:100-201; C:4-99; C:100-201CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
4LLDB:STRUCTURE OF WILD-TYPE IGG1 ANTIBODY HEAVY CHAIN CONSTANT DOMAIN 1 AND LIGHT CHAIN LAMBDA CONSTANT DOMAIN (IGG1 CH1:CLAMBDA) AT 1.19A
4LLUB:1-107; B:108-210; D:1-106; D:110-209STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
4LLVA:; B:; C:; D:; E:; F:; H:; L:THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
4LMQI:1-107; L:1-107DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4LSPL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4LSQL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
4LSSL:3-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120
4LSTL:1-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120
4LSUL:2-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4M1DL:1-106A; L:107-211; M:2-106A; M:107-209CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4M5YL:1-106A; L:107-209; M:1-106A; M:107-209CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
4M5ZL:1-106A; L:107-210CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 5J8 BOUND TO 2009 PANDEMIC INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4M6ML:1-112CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
4M6OL:1-107CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4MAYC:2-113CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4MNGE:2-119; E:147-256; F:2-119; F:147-256STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MQ7A:184-278STRUCTURE OF HUMAN CD1D-SULFATIDE
4N0FA:177-267; E:177-267; H:177-267; K:177-267HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
4NDMA:9-118; B:1-121STRUCTURE OF THE AB18.1 TCR
4NM4L:1-107; M:1-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4NPYA:1-106A; A:107-208; L:1-106A; L:107-209CRYSTAL STRUCTURE OF GERMLINE FAB PGT121, A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4NQTA:237-341; A:342-444ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER
4NQUA:237-341; A:342-444ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER
4NRYB:1-107; B:108-211; L:1-107; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
4NRZB:1-107; L:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4NZRL:1-107CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
4NZTL:2-107CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4NZUL:1-107CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT
4OAWC:1-107FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4OCSL:3-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD1L:3-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD3L:2-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4PS4L:1-106CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
(-)
Ictalurus punctatus [TaxId: 7998] (6)
2QHLA:; B:; C:; D:; E:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 10 EXTRACELLULAR FRAGMENT FROM ICTALURUS PUNCTATUS
2QJDA:; B:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 10 EXTRACELLULAR FRAGMENT MUTANT N30D
2QQQA:; B:; C:; D:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 11 EXTRACELLULAR FRAGMENT FROM ICTALURUS PUNCTATUS
2QTEA:; B:; C:; D:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 11 EXTRACELLULAR FRAGMENT MUTANT N30D
3B5TA:; B:; C:; D:; E:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 10 SE-MET EXTRACELLULAR FRAGMENT MUTANT N30D
3BDBA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 11 EXTRACELLULAR FRAGMENT FROM ICTALURUS PUNCTATUS INCLUDING STALK REGION
(-)
Llama (Lama glama) [TaxId: 9844] (5)
3K3QA:CRYSTAL STRUCTURE OF A LLAMA ANTIBODY COMPLEXED WITH THE C. BOTULINUM NEUROTOXIN SEROTYPE A CATALYTIC DOMAIN
3V0AC:2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
4KROB:NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4NBZB:; D:CRYSTAL STRUCTURE OF TCDA-A1 BOUND TO A26.8 VHH
4NC2B:CRYSTAL STRUCTURE OF TCDB-B1 BOUND TO B39 VHH
(-)
Mouse (Mus musculus) [TaxId: 10090] (360)
1SEQL:1-106AFAB MNAC13
1WC7A:1-107; L:1-107FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBA:1-107; L:1-107PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1XGPA:0-107STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGQA:0-107STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGRA:0-107STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGTA:0-107STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1YJDL:1-107CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
1YNTA:1-107; C:1001-1107STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1YQVL:0-107THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
1YY9C:1-107; C:108-211STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC-C225
1Z5LA:186-279; C:186-279STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1ZHNA:186-279CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE
1ZOXA:CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
1ZTXL:1-107WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2A1WL:114-216; M:114-216ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I
2A6JA:1-107; L:1-107CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65
2A77L:114-216ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II
2ADGA:1-107CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
2ADIA:1-107CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
2ADJA:1-107CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
2AEPL:1-107AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2AEQL:AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2AI0L:114-217; M:114-217; N:114-216; O:114-217ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III
2AJSL:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL
2AJUL:1-107CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB'
2AJVL:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE
2AJXL:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG
2AJYL:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID
2AJZA:1-107; L:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER
2AK1L:1-107CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID
2B2XL:1-114; M:1-114VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
2BMKA:1-107; L:1-107FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2BOCB:1-107POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2C1OA:1-107; A:108-212; L:1-107; L:108-212ENAIIHIS FAB FRAGMENT IN THE FREE FORM
2C1PA:1-107; L:2-107FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
2D03L:115-218CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
2E27L:CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
2EH7L:1-107CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
2EXYD:1-106; F:1-106CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS
2FATL:1-106AAN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2FIKA:186-279STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D
2G2RA:1-107; L:1-107GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
2G60L:109-208STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
2GCYA:1-110HUMANIZED ANTIBODY C25 FAB FRAGMENT
2GJJA:-1-114; A:136-253; B:-1-113; B:136-253CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2
2GJZA:109-212; L:109-212STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2GK0A:109-212; L:109-212STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2GKIA:23-132; A:159-273; B:23-132; B:159-274HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
2GSGA:; C:CRYSTAL STRUCTURE OF THE FV FRAGMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
2H2PD:1-106; F:1-106CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-
2H2SD:1-106; F:1-106CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
2I9LA:1-112; C:1-112; E:1-112; G:1-112STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
2J4WL:1-107STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J5LB:1-107STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2LQRA:NMR STRUCTURE OF IG3 DOMAIN OF PALLADIN
2NR6C:1-107; E:1-107CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2O5XL:108-213CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS-ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
2O5YL:108-213CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
2O5ZL:108-213CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA-ANDROSTANE-3,17-DIONE COMPLEX
2OR7A:; B:TIM-2
2OR8A:; B:TIM-1
2OYPA:T CELL IMMUNOGLOBULIN MUCIN-3 CRYSTAL STRUCTURE REVEALED A GALECTIN-9-INDEPENDENT BINDING SURFACE
2OZ4L:1-107STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2P1YE:302-412; G:302-4121.B2.D9, A BISPECIFIC ALPHA/BETA TCR
2Q86A:0-110; A:111-191; B:3-111; C:0-110; C:111-192; D:3-111STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
2Q8AL:1-107STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2Q8BL:1-107STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2R29L:1-111NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2R9HD:1-106; F:1-106CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
2RGSA:237-339; A:340-442; B:237-339; B:340-443FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
2V17L:1-107STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2V7HA:1-107; L:1-107CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2VC2L:1-107RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2VDKL:1-107RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDLL:1-107RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDML:1-107RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
2VDNL:1-107RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
2VL5B:1-111; D:1-111STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2VXTL:1-107CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
2VXUL:1-107; M:1-107CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
2W60B:1-112ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2W9DL:1-106STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION.
2W9EL:1-109STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
2XKNA:1-107; C:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2XQYK:1-107; L:1-107CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2YMXL:1-107; L:108-213CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408
2YPVL:1-107CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2YZ1A:; B:CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF MURINE SHPS-1/SIRP ALPHA
2Z91B:1-107; D:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2Z92B:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2ZCHL:1-107CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3AB0C:; F:CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT
3ARBC:1-117; D:3-118TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3ARDC:1-117; D:3-118; D:119-247TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3AREC:1-117; D:3-118TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3ARFC:1-117; D:4-118TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3ARGC:1-117; D:3-118; D:119-246TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2)
3AXLA:3-129; B:3-129; G:3-129; H:3-129MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR
3BGFC:1-107; L:1-107X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3BI9X:TIM-4
3BIAX:TIM-4 IN COMPLEX WITH SODIUM POTASSIUM TARTRATE
3BIBX:TIM-4 IN COMPLEX WITH PHOSPHATIDYLSERINE
3BKCL:1-106A; L:107-212CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB)
3BKML:1-106A; L:107-212STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121)
3BQUC:1-104; C:108-209CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BT2L:1-106ASTRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3BZ4A:1-107; C:1-107; E:1-107; G:1-107CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3C5SA:1-107; C:1-107CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
3C5ZA:1-112; B:1-112; E:1-112; F:1-112CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3C60A:1-111; B:1-111; E:1-111; F:1-111CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3C6SA:1-107; C:1-107; E:1-107; G:1-107CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
3CFBA:1-107; L:1-107HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
3CFCL:1-107HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
3CFDA:1-107; L:1-107PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3CFEA:1-107; L:1-107CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3CFJA:1-106; C:1-106; E:1-106; L:1-106CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM
3CMOL:1-107; X:2-107HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3CVHL:1-106; R:1-106HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CVIL:1-106HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3D9AL:1-107HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
3E8UL:1-107CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
3EFDL:1-107THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA
3EOTL:1-111CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB
3ESUF:1-106; F:1004-1113CRYSTAL STRUCTURE OF ANTHRAX-NEUTRALIZING SINGLE-CHAIN ANTIBODY 14B7
3ESVF:-1-106; F:1002-1113; G:-1-106; G:1003-1113CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18
3ET9F:0-106; F:1003-1113CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY 1H
3FB6B:1-107KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
3FFDB:1-116; B:117-217STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY
3FO0L:113-216CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
3FO1A:113-216; L:113-216CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
3FO2A:113-216; L:113-216CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
3G5ZA:1-110ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3GI8L:1-113CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GI9L:1-113CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GK8L:1-107; L:108-214X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14, MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
3GKZA:9-116; A:143-250CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE
3GM0A:9-125; A:142-250ANTI-METHAMPHETAMINE SINGLE CHAIN FV IN COMPLEX WITH MDMA
3GMLA:186-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH
3GMMA:186-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH
3GMNA:186-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH
3GMOA:186-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF
3GMPA:186-281STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25
3GMQA:186-281STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED
3GMRA:186-279STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP
3H3BC:-2-112; C:136-253; D:-2-113; D:136-253CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI-ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN
3HE6A:186-299; C:1-117; D:3-118CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3HE7A:186-299; C:1-117; D:2-118; D:119-247CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
3HNSL:1-107CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
3HNTL:1-107CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
3HNVL:1-107CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3HZKA:1-106CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3HZMA:1-106CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3HZVA:1-106CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3HZYA:1-106CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I02A:1-106; C:1-106CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I2CL:1-111CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
3I50L:1-107CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
3I75A:1-107ANTIBODY STRUCTURE
3I9GL:1-107CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3IF1A:113-212; C:113-212CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3IJHA:2-106; C:2-106STRUCTURE OF S67-27 IN COMPLEX WITH KO
3IJSA:2-106; C:2-106STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3IJYA:2-106; C:2-106STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3IKCA:2-106; C:2-106STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3IU4L:1-107ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
3IVKB:1-108; L:1-108CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3IXTB:1-107; L:1-107CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3KAAA:; B:STRUCTURE OF TIM-3 IN COMPLEX WITH PHOSPHATIDYLSERINE
3KHOA:; B:CRYSTAL STRUCTURE OF MURINE IG-BETA (CD79B) HOMODIMER
3KHQA:CRYSTAL STRUCTURE OF MURINE IG-BETA (CD79B) IN THE MONOMERIC FORM
3KJ4B:1-112; L:1-112STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3KS0J:1-110; J:111-212; L:1-110; L:111-212CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
3L1OL:1-107CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC
3L5WA:1-107; L:1-107CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
3L7EA:1-107; L:1-107CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3LIZL:1-107CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
3LS4L:1-108CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
3LS5L:1-108ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM
3MBXL:1-113CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3MCLL:1-105ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3MNVA:-1-107; A:108-213; C:-1-107; C:108-212CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3MO1A:0-107; A:108-211CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3MXVL:1-107CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3NIDF:1-107; L:1-107THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIFF:1-107; L:1-107THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIGF:1-107; L:1-107THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3O0RL:1-107CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3O11A:1-105; L:1-105ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3O2DL:1-106CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3O2VL:108-213CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
3O2WL:108-213CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
3O6KL:1-112CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1
3O8XC:1-117RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WC:1-117RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3OJDA:1-107ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3OKDA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3OKEA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3OKKA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3OKLA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
3OKMA:1-107CRYSTAL STRUCTURE OF UNLIGANDED S25-39
3OKNA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3OKOA:1-107CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3OZ9L:1-110CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3PHOA:2-110CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
3PHQA:2-110CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
3PP3K:1-112; L:1-112EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
3PXHA:30-124; A:125-226TANDEM IG DOMAINS OF TYROSINE PHOSPHATASE LAR
3Q3GA:1-113; C:1-113; F:1-113; J:1-113CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3Q5TA:3-115V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3Q5YA:0-117; B:1-117; C:1-117; D:1-117V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3QI9C:1-117; D:1-118CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3QIBD:2-116CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QIUC:2-109; D:2-116CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
3QJFA:2-111; B:2-115; B:116-243; C:1-111; D:4-115; D:116-244CRYSTAL STRUCTURE OF THE 2B4 TCR
3QJHA:1-117; B:2-119; C:1-117; D:2-119THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR
3QUXC:1-117; D:113-240STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYC:1-117; D:113-240STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZC:1-117; D:113-240STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3QWOB:1-107; L:1-107CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3RA7L:1-107; M:1-107BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3RAJL:1-105CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7
3RGVA:1-110; B:1-112A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3RKDC:1-107; L:1-107HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3RTQC:1-117; D:113-240STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3RUGE:3-129; F:3-128; G:3-129; H:3-128CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2)
3RVTC:1-110STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3RVUC:1-110STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
3RVV  [entry was replaced by entry 5VPL without any SCOP domain information]
3RVW  [entry was replaced by entry 5VPG without any SCOP domain information]
3RVX  [entry was replaced by entry 5VPH without any SCOP domain information]
3RZCC:1-117; D:113-240STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3S34L:1-107STRUCTURE OF THE 1121B FAB FRAGMENT
3S35L:1-111STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3S37L:2-107STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3S96B:241-357; B:358-458; D:242-357; D:358-458CRYSTAL STRUCTURE OF 3B5H10
3SCMC:1-117; D:1-118CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3SDAC:1-117; D:1-118CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDCA:186-295; C:1-117; D:1-119CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
3SDDA:186-295; C:1-117; D:1-119CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
3SGDI:1-112; L:1-112CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3SGEI:1-112; L:1-112CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3T3MF:1-107; L:1-107A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3T3PF:1-107; L:1-107A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3TA3C:1-117STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3TO4A:186-299STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TT1L:1-111; M:1-111CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3TVMC:1-117; G:1-117STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3U0WL:1-107AD RELATED MURINE ANTIBODY FRAGMENT
3UBXA:186-286; D:186-286; I:1-107; L:1-107CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3UJTL:1-107; M:1-107STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O-ANTIGEN OF FRANCISELLA TULARENSIS
3UMTA:3-113; A:138-244SCFV12, ANTI-BCLA ANTIBODY SINGLE CHAIN VARIABLE FRAGMENT
3UTZA:113-216; D:113-216; E:113-216ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
3UYPA:2-117; A:135-244CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3UZEA:2-117; A:133-245; B:2-117; B:134-243CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3UZQA:3-117; A:134-245CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3UZVB:2-117; B:133-244CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3V0VB:1-107; L:1-107FAB WN1 222-5 UNLIGANDED
3V0WL:1-107CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
3V4PL:114-217; N:114-217CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
3V4VL:114-217; N:114-217CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
3V6FB:1-114; D:1-114; F:1-114; L:1-114CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND
3V6OE:4-109; F:4-109LEPTIN RECEPTOR-ANTIBODY COMPLEX
3VFGL:1-107CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
3VG0L:3-109ANTIBODY FAB FRAGMENT
3VG9B:1-107CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
3VGAB:1-107CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
3VI3E:1-112; L:1-112CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3WKML:1-111; L:112-215; M:1-111; M:112-214THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
3ZDXF:1-107; L:1-107INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3ZKMD:1-111; L:1-111BACE2 FAB COMPLEX
3ZKND:1-111; L:1-111BACE2 FAB INHIBITOR COMPLEX
3ZO0A:237-339; A:340-444MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY
4AEHL:1-107CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
4AG4L:1-107CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4APQA:186-295; C:1-119; D:1-118; D:119-244CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
4BA8A:HIGH RESOLUTION NMR STRUCTURE OF THE C MU3 DOMAIN FROM IGM
4C83B:1-107; B:108-214; D:2-107; D:108-214CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8-SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS
4CADA:2-107; A:108-212; D:2-107; D:108-212; G:1-107; G:108-212; J:1-107; J:108-212MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4DCQA:1-115; A:116-218CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10, AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
4DGIL:1-107STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120-230
4DVBB:1-108; L:1-108THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4DW2L:1-107THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112
4EBQL:2-110FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
4EDXA:1-107; L:1-107NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
4EI5C:2-114; D:2-115; D:116-243; E:186-290; G:2-114; H:1-115; H:116-237CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4EI6A:2-114; B:0-115; C:2-114; D:3-115STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4ELKA:3-115; B:3-116; C:3-115; D:2-116CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
4ETQB:2-110; L:2-110VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4F15C:1-110; F:1-110; I:1-110; L:1-110MOLECULAR BASIS OF INFECTIVITY OF 2009 PANDEMIC H1N1 INFLUENZA A VIRUSES
4F2MB:1-107; D:1-107CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4F33A:2-106; C:2-106; E:2-106; G:2-106CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4F3FA:2-106CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4F9LC:1-109; C:132-254; D:1-109; D:132-254CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
4FFVC:1-106; L:1-106CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB
4FFWC:1-106; L:1-106CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4FG6D:1-106; F:1-106STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4GAYB:1-107; L:1-107STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4GMSL:1-107; M:1-107; N:1-107CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4GMTL:1-107; M:1-107CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
4GQ9L:1-109CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
4H0GA:1-120; A:140-251CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
4H0HB:1-120; B:140-251CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE
4H0IA:1-120; A:140-251CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D-MANNOPYRANOSIDE
4H20L:1-107CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18
4H88L:1-107STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120-230
4HLZH:3-109; J:3-109; L:3-109CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HXAL:1-107CRYSTAL STRUCTURE OF 13D9 FAB
4HZLB:114-217; L:114-217NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
4I9WD:1-106; F:1-106HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4IJ3B:1-107; B:108-214OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY
4IRJA:186-279; C:2-115; D:2-112; D:113-240STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4IRSC:1-114STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
4ISVA:1-116; A:117-217CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
4J1UA:1-112; C:1-112; E:3-112CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
4JJ5A:1-115; A:119-207CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
4JN1L:2-113AN ANTIDOTE FOR DABIGATRAN
4JN2A:2-113; L:2-113AN ANTIDOTE FOR DABIGATRAN
4JQIL:1-108STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
4JR9L:1-106CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
4JREC:1-106; L:1-106CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
4JVUA:; B:IGM C2-DOMAIN FROM MOUSE
4JVWA:; B:; C:; D:IGM C4-DOMAIN FROM MOUSE
4JZJB:1-113; L:1-113CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
4K23L:1-107STRUCTURE OF ANTI-UPAR FAB ATN-658
4K2UL:1-107; L:108-210; M:1-107; M:108-200CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
4K7PL:1-107GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4K9EL:2-110CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D
4KI5D:1-106; D:107-213; F:1-107CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4KJWD:1-106; F:1-106STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KK5D:1-106; F:1-106STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KK6D:1-106; F:1-106STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KK9D:1-106; F:1-106STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4KKAD:1-106; F:1-106STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KKBD:1-106; F:1-106STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KKCD:1-106; F:1-106STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KPHL:1-107; M:1-107STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
4KQ4L:1-107CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
4KROC:1-107; C:108-211NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4KRPC:1-107NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4KUCD:21-126; D:127-228; E:CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2
4KUZL:1-112CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4L5FL:1-107; L:108-213CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
4LAQH:; L:CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4LARL:CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4LASL:CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4LEOB:1-113CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3)
4LEXL:1-112UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4LF3A:1-106; D:1-106INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR
4LVHC:1-110; F:1-110; I:1-110; L:1-110INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ
4M43L:1-107CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
4M48L:1-108; L:109-214X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM
4M61A:1-112; C:1-112CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
4M7KL:1-113CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
4MA7L:1-107CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
4MA8L:1-107CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
4MAUL:1-111CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4NCC1:1-106; L:1-106NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
4NOBA:CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
4NX3  [entry was replaced by entry 4WEB without any SCOP domain information]
(-)
Murinae, homo sapiens [TaxId: 39107] (2)
4GW1A:1-107; C:1-107CQFD MEDITOPE
4GW5A:1-107; C:1-107CQYN MEDITOPE - CETUXIMAB FAB
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (2)
1ZANL:1-108; L:109-214CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
3U9PL:1-107; L:108-212; M:1-107; M:108-211CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
(-)
Rabbit (Oryctolagus cuniculus) [TaxId: 9986] (10)
2RIKA:-2-92; A:93-186; A:187-280I-BAND FRAGMENT I67-I69 FROM TITIN
2RJMA:-2-92; A:93-186; A:187-2803IG STRUCTURE OF TITIN DOMAINS I67-I69 E-TO-A MUTATED VARIANT
2VUOA:230-341; A:342-444; B:231-341; B:342-444CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
4HBCL:1-116; L:117-213CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS
4HT1L:1-111HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
4JO1L:2-108; L:109-211; M:2-108; M:109-211CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
4JO2L:2-108; L:109-211; M:2-108; M:109-211CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
4JO3L:1-107; L:108-211; M:1-107; M:108-211CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
4JO4L:1-107; L:108-211; M:1-107; M:108-211CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
4MA3A:1-112; A:113-219; L:1-112; L:113-219CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
3B9KC:108-214; L:108-214CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
(-)
Rhesus monkey (Macaca mulatta) [TaxId: 9544] (3)
3Q6GL:2-107; M:2-107CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4KTDL:2-107FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE136, FROM NON-HUMAN PRIMATE
4KTEL:1-107FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE148, FROM NON-HUMAN PRIMATE
(-)
Family: C1 set domains (antibody constant domain-like) (3013)
(-)
Protein domain: automated matches (652)
(-)
Chimpanzee (Pan troglodytes) [TaxId: 9598] (1)
3UC0L:109-210; M:109-212CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
3L9RA:184-278; C:184-278; E:184-278; G:184-278CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
(-)
Escherichia coli [TaxId: 562] (1)
3TYFA:115-202; B:119-247; C:115-202; D:119-247CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
(-)
Human (Homo sapiens) [TaxId: 9606] (334)
1TZGL:107-213; M:107-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1U6AL:108-213CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1ZA6A:114-220; C:114-220; E:114-220; G:114-220THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSL:108-210FAB 2G12 + MAN4
1ZLUK:108-212; L:108-212FAB 2G12 + MAN5
1ZLVK:108-212; L:108-212FAB 2G12 + MAN7
1ZLWK:108-212; L:108-210FAB 2G12 + MAN8
2AGJL:108-215CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2AJ3A:108-213; C:108-213; E:108-213CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
2BC4A:97-200; B:94-193; C:97-206; D:94-199CRYSTAL STRUCTURE OF HLA-DM
2BNUA:116-204STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDGA:116-193STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2CMRL:107-207CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
2D4DA:THE CRYSTAL STRUCTURE OF HUMAN BETA2-MICROGLOBULIN, L39W W60F W95F MUTANT
2EYRA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYSA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYTA:118-205; B:120-247; C:118-205; D:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2FJFA:108-211; C:108-211; E:108-211; G:108-211; J:108-211; L:108-211; M:108-211; O:108-211; Q:108-211; S:108-211; U:108-211; W:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGA:108-211; L:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHA:107-211; L:107-214STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FSEA:82-181; C:82-180CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2H9GA:108-211; L:108-211CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFA:107-213; L:107-210CRYSTAL STRUCTURE OF CB2 FAB
2HFGL:107-212CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2IALA:110-198; B:113-240; C:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAMC:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAND:110-198; E:113-240; I:110-198; J:113-240; N:110-198; O:113-240; S:110-198; T:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2J6EA:236-339; A:340-445; B:238-339; B:340-446; M:109-211CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2JB5L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6A:113-214; L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2NW2A:118-206CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2NYYC:112-216CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2OLDA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM
2OMBA:113-217; B:113-217; C:113-217; D:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM
2OMNA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P4(3)2(1)2 CRYSTAL FORM
2PYFA:116-205; B:114-241CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2QQKL:108-211NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQLL:107-214NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQNL:108-214NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2R56L:108-211; M:108-211CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2VLMD:113-201THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VXQL:108-213CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2VXSL:109-210; M:109-212; N:109-210; O:109-212STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY
2VXVL:108-213CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2WAHA:238-339; A:340-444; B:237-339; B:340-445CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
2WBJB:93-188; C:114-200; F:93-190; G:114-202TCR COMPLEX
2WUBL:108-214; Q:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2WUCL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2X89D:; E:; F:; G:STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2XA8L:112-218CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2XKUA:PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2XNAA:112-200CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
2XPGB:CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
2XQBL:108-209CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
2XWTB:108-213CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2XZAL:110-216CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2XZCL:110-216CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2YK1L:108-205STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
2YKLL:108-208STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
3AGVA:241-339; A:340-443; B:237-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX
3BDYL:108-213DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BE1L:108-212DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3BN9C:108-210; E:108-211CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3BQUA:108-211CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BZFB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3C08L:107-211CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3C2SA:236-339; A:340-445STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS
3C5JB:93-190CRYSTAL STRUCTURE OF HLA DR52C
3D85A:108-213CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3DGGA:111-217; C:111-215CRYSTAL STRUCTURE OF FABOX108
3DIFA:108-213; C:108-214CRYSTAL STRUCTURE OF FABOX117
3DX9A:126-215; B:130-257; C:126-215; D:130-257CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EO9L:108-213CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
3EOAA:108-214; L:108-214CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I
3EYOA:109-213; C:109-214CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3EYQC:109-212CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3F12A:110-212; C:110-214GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
3FJTA:236-339; A:340-444; B:236-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
3FZUD:108-213; L:108-213IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3G6AA:109-210; L:109-210CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3G6JE:107-214; G:107-214C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3GBML:108-213; M:112-211CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3GIZL:108-211CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB
3GJEA:111-212; L:111-212RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GKWL:108-207CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3GRWL:108-214FGFR3 IN COMPLEX WITH A FAB
3GSNA:112-200; B:117-244; H:182-274CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3GSOA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
3GSQA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
3GSRA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
3GSUA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
3GSVA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
3GSWA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
3GSXA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
3H0TA:112-216HEPCIDIN-FAB COMPLEX
3H42L:113-214CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3H9YA:336-438; A:439-544; B:335-438; B:439-544; E:336-438; E:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3H9ZA:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HA0A:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544; E:336-438; E:439-544; F:336-438; F:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HC0B:108-213; L:108-212BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3HC3L:108-213BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HC4L:108-213BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HI1A:108-214; L:108-214STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING-SITE ANTIBODY F105
3HI5L:107-211CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3HI6L:107-211; Y:107-210CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3HMWL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3HMXL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3HUJE:118-206; F:119-247; G:118-206; H:119-247CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3IDXL:108-213CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
3INUL:108-211; N:108-211CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3JWDL:108-214; O:108-213STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3K2UL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3KR3L:109-214CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
3KYMA:108-213; C:108-213; E:108-213; G:108-213; I:108-213; K:108-212; M:108-208; O:108-213CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3L5XL:108-214CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3L7FA:108-213; D:108-213; L:108-213STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836
3LMJL:113-215STRUCTURE OF HUMAN ANTI HIV 21C FAB
3LRSB:108-209; D:108-209; F:108-209; L:108-209STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3LZFL:108-211CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3M1BA:177-267; C:177-267; E:177-267; G:177-267CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
3M8OL:113-219HUMAN IGA1 FAB FRAGMENT
3MFFA:122-210; B:116-243; C:122-210; D:116-2431F1E8HU TCR
3MLRL:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
3MLSL:112-213; M:112-213; N:112-213; O:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV-1 GP120 V3 MIMOTOPE
3MLTA:112-213; D:112-213; G:112-213; L:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3MLUL:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
3MLVL:113-213; M:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3MLWL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3MLXL:109-209; M:109-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3MLYL:108-211; M:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3MLZL:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
3MUGA:108-212; C:108-212; E:108-212; G:108-212; I:108-212; K:108-213CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3MUHL:108-212CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3MXWL:108-212CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3N9GL:112-220CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI-WEST NILE VIRUS MAB CR4354
3NA9L:108-214CRYSTAL STRUCTURE OF FAB15
3NAAL:108-214CRYSTAL STRUCTURE OF FAB15 MUT5
3NABL:108-214CRYSTAL STRUCTURE OF FAB15 MUT6
3NACL:108-214CRYSTAL STRUCTURE OF FAB15 MUT7
3NCJL:108-214CRYSTAL STRUCTURE OF FAB15 MUT8
3NFPB:107-212; L:107-212CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3NFSL:107-212CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3NPSC:108-212CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3NZHL:108-214CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
3O4LD:112-201GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3O6FC:111-196; G:111-196CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3OAYK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OAZK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OB0K:108-213; L:108-212A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OF6A:120-245; B:120-247; C:120-247HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3P0VL:108-212; M:108-212ANTI-EGFR/HER3 FAB DL11 ALONE
3P0YL:108-213ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3PGFL:108-214CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3PL6B:95-191; C:114-192STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3PWPE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3Q6FA:108-211; C:108-211; E:108-211; G:108-211; I:108-211; K:108-211CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3QDGD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMD:110-196; E:116-243THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEGL:108-212CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEHB:107-210; D:107-210; F:107-210; H:107-210CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEQD:110-195THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEUA:111-201; B:118-241; D:111-201; E:118-245THE CRYSTAL STRUCTURE OF TCR DMF5
3QFJE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QH3A:112-194; B:117-245; C:112-194; D:117-245THE CRYSTAL STRUCTURE OF TCR A6
3QHFL:108-213CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
3QHZL:108-215; M:108-212CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3QIBC:112-201CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QNXA:113-219ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QNYA:113-219; C:113-219MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QO1A:113-219MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3QOS  [entry was replaced by entry 5I1D without any SCOP domain information]
3QOT  [entry was replaced by entry 5I18 without any SCOP domain information]
3QPQC:108-215; E:108-215; I:108-215; L:108-215CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3QPXL:107-213CRYSTAL STRUCTURE OF FAB C2507
3QQ9C:112-217; L:112-217CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3QRGL:112-217CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3R1GL:108-214STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3REVA:118-205; B:116-242CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RPIB:97-202; L:97-202CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY
3S7GA:236-339; A:340-443; B:236-339; B:340-442; C:237-339; C:340-444; D:238-339; D:340-444AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3SDXE:115-203; G:115-203CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDYL:108-214CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
3SE8L:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
3SE9L:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG04 IN COMPLEX WITH HIV-1 GP120
3SKJL:108-214; M:108-214STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3SKNA:125-214; B:127-255; C:125-214; D:127-255; E:125-214; F:127-255; G:125-214; H:127-255CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3SO3B:108-213STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
3T2NL:109-209; M:109-210HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3TCLB:108-213; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3THML:112-214CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3TJEL:112-213CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
3TNMB:108-208; L:108-208CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3TNNB:109-210; D:109-210; F:109-210; L:109-210CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3TO4C:118-207; D:122-247STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TV3L:108-211CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
3TWCL:108-214CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
3TZVA:115-200; G:115-203CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U2SB:108-208; L:108-208CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
3U30B:108-211; E:108-211CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3U46B:108-213; L:108-213CH04H/CH02L P212121
3U4BL:108-213CH04H/CH02L FAB P4
3U4EB:108-209; L:108-210CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3UTPD:113-200; E:118-246; K:113-202; L:118-2461E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
3V7MA:236-339; A:340-444CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+
3VWJC:118-206TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKC:118-204; D:119-246TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
3VXQA:114-204; D:114-204H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3VXTA:112-200; C:112-200T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3W9DB:108-212; D:108-213STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3W9EB:108-211STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
3WD5L:107-213CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3ZL4L:111-216ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
4AENB:93-190HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4AL8L:108-213STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AM0B:108-212; D:108-212; F:108-212; L:108-212STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4B7IA:237-339; A:340-444; B:238-339; B:340-444CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS
4D9LL:109-209; M:109-210; N:109-210; O:109-210FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4D9QD:108-213; L:108-213INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4D9RD:108-213; L:108-214INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4DKFL:107-212; M:107-208CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4DN3L:109-214CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4DQOL:108-210CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4DTGL:112-219HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4DZBA:111-199; B:118-245MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2
4E41D:111-199; E:111-238; I:111-198; J:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4E42A:111-198; B:111-238; C:111-198; D:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4EDWL:108-214NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4EN3A:114-201CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4EOWL:112-212CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4ERSL:107-214A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
4EVNB:113-215; D:113-215; F:113-215; H:113-215; J:113-215; L:113-215; N:113-215; P:113-215CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE-REVERTED LIGHT CHAIN)
4F57L:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4F58L:109-209; M:109-209; N:109-209; O:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4FNLL:107-213; M:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4FP8L:107-213; M:107-213; N:107-213; O:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4FQ2L:109-212CRYSTAL STRUCTURE OF 10-1074 FAB
4FQHB:108-209; L:108-209CRYSTAL STRUCTURE OF FAB CR9114
4FQIL:108-208CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4FQJL:108-211INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4FQLL:108-214INFLUENZA B HA ANTIBODY (FAB) CR8033
4FQQA:109-210; C:109-209; E:109-209; L:109-212CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4FQXB:93-190; C:97-200; D:94-193CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
4FZ8L:108-211CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4FZEL:108-210CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4G3YL:108-214CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4G7VL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)
4G7YL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)
4G8EA:128-217; B:135-262CRYSTAL STRUCTURE OF CLONE18 TCR
4G8FA:129-205; B:128-256CRYSTAL STRUCTURE OF CLONE42 TCR
4GKZA:116-201; B:115-242HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4GRLA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4GRMA:118-194; B:118-246; C:118-193; D:118-245THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4GSDL:109-211H5.3 FAB STRUCTURE
4GT7A:334-438; A:439-545; B:333-438; B:439-545; C:332-438; C:439-545; D:333-438; D:439-545AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION
4GW4B:97-199; L:97-198CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4GXVL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4H25B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
4H26B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
4H8WL:109-209CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4HCRL:112-218; N:112-218CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
4HF5L:108-208CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFUL:107-212CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFWA:107-211; L:107-212ANTI ROTAVIRUS ANTIBODY
4HH9A:108-214; C:108-214ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4HJGA:108-214MEDITOPE-ENABLED TRASTUZUMAB
4HK0B:110-210; D:110-210UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HK3N:110-210I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HKXB:110-211INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
4HKZA:108-213TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4HQQL:108-208CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4HWEL:105-210CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4I2XA:108-214; C:108-214CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
4I3RL:107-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4I3SL:108-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4I77L:108-214LEBRIKIZUMAB FAB BOUND TO IL-13
4IIQA:111-201; B:117-244CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4IOIA:108-214MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4IRJC:116-204STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4J12A:236-339; A:340-444MONOMERIC FC
4J4PD:131-233; L:131-233THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4J6RL:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
4JAMB:108-209; L:108-209CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
4JANB:106-207; L:106-207CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4JB9L:103-209CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4JDVB:104-209; L:104-209CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4JFHD:111-200; E:117-244HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JFXA:108-214; L:108-214STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4JFYA:108-211; L:108-213APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
4JFZL:108-214STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG0L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG1L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
4JHAL:108-211CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4JM2B:107-214; C:110-212CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4JM4L:108-214CRYSTAL STRUCTURE OF PGT 135 FAB
4JPIB:110-214; L:110-213CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPKL:110-214CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPVL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4JPWL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4JY5L:109-209CRYSTAL STRUCTURE OF HUMAN FAB PGT122, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4K71B:177-268; E:177-268CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
4K7PX:108-214GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4KMTL:108-214CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4KQ3L:107-211CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4KVNL:107-212CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
4KY1L:108-213HUMANIZED HP1/2 FAB
4L4TD:111-200; G:111-199STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VD:111-200; G:111-198STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4L8SA:111-200CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4LCWD:111-200; G:111-198THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LFHG:126-238CRYSTAL STRUCTURE OF 9C2 TCR
4LHUG:126-236CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4LKCA:109-214AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4LMQI:108-214; L:108-214DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4LSPL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4LSQL:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
4LSUL:108-211CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4M6ML:113-216CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
4M6OL:108-214CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4MAYA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4MNGA:184-278; C:184-278STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MWFB:108-213; L:108-213STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4NDMA:119-246; B:122-212STRUCTURE OF THE AB18.1 TCR
4NM4L:108-213; M:108-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4NRZB:108-212; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4NZRL:108-214CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
4NZTL:108-212CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4NZUL:108-211CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT
4OAWC:108-214FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4OCSL:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD1L:108-208CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD3L:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4PS4L:107-213CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
(-)
Mouse (Mus musculus) [TaxId: 10090] (309)
1SEQL:107-211FAB MNAC13
1T2QL:115-218THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
1UYWL:108-212; N:108-211CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
1WC7A:108-214; L:108-213FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBA:108-214; L:108-214PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1XGPA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGQA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGRA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGTA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1YJDL:108-212CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
1YNTA:108-213; C:1108-1213STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1YQVL:108-212THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
1ZTXL:108-212WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2A6JA:108-214; L:108-214CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65
2ADFL:107-209CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
2ADGA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
2ADIA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
2ADJA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
2AJSL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL
2AJUL:108-211CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB'
2AJVL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE
2AJXL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG
2AJYL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID
2AJZA:108-211; L:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER
2AK1L:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID
2B2XL:115-215; M:115-215VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
2BMKA:108-214; L:108-214FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2BOCB:108-212POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2C1PA:108-213; L:108-213FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
2DDQL:113-218CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
2DQTL:108-214HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DQUL:108-214CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DTML:108-213THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
2EH7L:108-214CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
2EXYD:107-211; F:107-211CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS
2FATL:107-213AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2FSEB:93-190; D:93-189CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2G2RA:108-214; L:108-214GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
2GCYA:111-216HUMANIZED ANTIBODY C25 FAB FRAGMENT
2H2PD:107-211; F:107-211CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-
2H2SD:107-211; F:107-211CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
2HKHL:113-219CRYSTAL STRUCTURE OF THE FAB M75
2I9LA:113-219; C:113-219; E:113-219; G:113-219STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
2IPTL:107-213PFA1 FAB FRAGMENT
2IQ9L:107-213PFA2 FAB FRAGMENT, TRICLINIC APO FORM
2IQAA:107-213; L:107-213PFA2 FAB FRAGMENT, MONOCLINIC APO FORM
2J4WL:108-214STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J5LB:108-214STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2NR6C:108-211; E:108-211CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2NTFA:109-211; L:109-211CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N-ACYL-L-HOMOSERINE LACTONE ANALOG
2OP4L:109-212CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
2ORBL:108-212; M:108-213THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
2OZ4L:108-214STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2Q8AL:108-214STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2Q8BL:108-213STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2R0WL:107-213PFA2 FAB COMPLEXED WITH ABETA1-8
2R0ZL:107-213PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
2R29L:112-213NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2R9HD:107-211; F:107-211CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
2UYLA:113-218; M:113-216; V:113-216; X:113-216CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2V17L:108-214STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2V7HA:108-214; L:108-214CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2VC2L:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2VDKL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDLL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDML:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
2VDNL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
2VL5B:112-217; D:112-216STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2VQ1A:108-212; E:108-212ANTI TRIMERIC LEWIS X FAB54-5C10-A
2VXTL:108-213CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
2VXUL:108-214; M:108-214CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
2W60B:113-217ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2W9DL:107-211STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION.
2W9EL:110-212STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
2XKNA:108-213; C:108-213CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2XQYK:108-214; L:108-214CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2YPVL:108-212CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2Z4QA:113-219CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2Z91B:108-212; D:108-213CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2Z92B:108-211CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2ZCHL:108-211CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3ARBC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3ARDC:118-207TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3AREC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3ARFC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3ARGC:118-207TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2)
3AU1A:186-279CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3
3AXLA:130-218; B:130-256; G:130-218; H:130-256MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR
3BGFC:108-211; L:108-212X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3BT2L:107-212STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3BZ4A:108-211; C:108-213; E:108-211; G:108-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3C5SA:108-213; C:108-212CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
3C5ZA:113-202; B:113-240; E:113-201; F:113-240CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3C60A:112-201; B:112-236; E:112-201; F:112-236CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3C6SA:108-211; C:108-213; E:108-211; G:108-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
3CFBA:108-213; L:108-213HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
3CFCL:108-214HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
3CFDA:108-213; L:108-213PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3CFEA:108-213; L:108-213CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3CLEL:108-212HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CLFL:108-214HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CMOL:108-211; X:108-211HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3CVHL:107-209; R:107-209HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CVIL:107-209HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3D9AL:108-213HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
3E8UL:108-212CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
3EFDL:108-211THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA
3EO0A:109-215; C:109-215STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
3EO1A:108-215; D:108-215; G:108-215; J:108-215STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3EOTL:112-214CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB
3FB6B:108-212KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
3FO9A:108-214; L:108-214CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3G08A:186-279CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
3G5XA:108-214; C:108-214ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3G5ZA:111-213ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3GI8L:114-220CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GI9L:114-219CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GNML:113-217THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3HE6C:118-208; D:119-247CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3HE7C:118-207CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
3HKFA:241-344; A:345-445MURINE UNGLYCOSYLATED IGG FC FRAGMENT
3HNSL:108-214CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
3HNTL:108-214CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
3HNVL:108-214CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3HZKA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3HZMA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3HZVA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3HZYA:107-210CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I02A:107-213; C:107-207CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I2CL:112-218CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
3I50L:108-208CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
3I75A:108-212ANTIBODY STRUCTURE
3I9GL:108-213CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3IETA:108-212; C:108-213CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3IJHA:107-212; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KO
3IJSA:107-212; C:107-211STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3IJYA:107-210; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3IKCA:107-212; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3ILPA:186-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
3ILQC:186-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
3IU4L:108-213ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
3IVKB:109-213; L:109-213CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3IXTB:108-211; L:108-212CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3KJ4B:113-219; L:113-219STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3L1OL:108-214CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC
3L5WA:108-213; L:108-213CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
3L7EA:108-213; L:108-213CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3LIZL:108-211CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
3LS4L:109-215CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
3LS5L:109-215ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM
3MA7A:186-279; C:186-279CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
3MBXL:114-220CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3MCKA:113-219; L:113-219CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
3MCLL:106-209ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3MXVL:108-212CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3NIDF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIFF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIGF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NZ8B:108-212; L:108-213CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3O0RL:108-213CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3O11A:106-212; L:106-212ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3O2DL:107-210CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3O6KL:113-217CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1
3O8XA:186-279; C:118-206; D:113-240RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WA:186-279; C:118-206; D:113-240RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3OJDA:108-214ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3OKDA:108-214CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3OKEA:108-212CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3OKKA:108-215CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3OKLA:108-214CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
3OKMA:108-214CRYSTAL STRUCTURE OF UNLIGANDED S25-39
3OKNA:108-213CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3OKOA:108-212CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3OZ9L:111-213CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3PHOA:111-217CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
3PHQA:111-217CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
3PP3K:113-219; L:113-219EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
3Q3GA:114-220; C:114-220; F:114-220; J:114-220CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3Q5TA:116-240V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3Q5YA:118-247; B:118-246; C:118-247; D:118-246V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3QA3A:121-220; C:121-220; F:121-220; J:121-220CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3QG7L:108-211STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
3QI9C:118-204; D:119-243CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3QIBA:82-180; B:94-186; D:117-243CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QIUA:82-181; B:93-186; C:110-186; D:117-243CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
3QJFA:112-201; C:112-199CRYSTAL STRUCTURE OF THE 2B4 TCR
3QJHA:118-206; B:120-247; C:118-206; D:120-246THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR
3QUXA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3QWOB:108-211; L:108-211CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3RA7L:108-211; M:108-211BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3RAJL:106-208CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7
3RGVA:111-200; B:113-236A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3RKDC:108-213; L:108-213HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3RTQA:186-279STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3RUGA:186-296; C:186-295; E:130-218; F:129-256; G:130-218; H:129-256CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2)
3RVTC:111-213STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3RVUC:111-212STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
3RVV  [entry was replaced by entry 5VPL without any SCOP domain information]
3RVW  [entry was replaced by entry 5VPG without any SCOP domain information]
3RVX  [entry was replaced by entry 5VPH without any SCOP domain information]
3RZCA:186-279STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3S34L:108-214STRUCTURE OF THE 1121B FAB FRAGMENT
3S35L:112-217STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3S37L:108-213STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3SCMC:118-204; D:119-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3SDAA:186-295; C:118-204; D:119-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDCC:118-204; D:120-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
3SDDC:118-203; D:120-242CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
3SGDI:113-218; L:113-218CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3SGEI:113-219; L:113-219CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3T1FA:186-279CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX
3T3MF:108-214; L:108-214A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3T3PF:108-214; L:108-214A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3TA3A:186-279; C:118-206; D:113-240STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3TT1L:112-215; M:112-215CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3TVMA:186-279; C:118-206; D:113-240; E:186-249; G:118-206; H:113-240STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3U0WL:108-213AD RELATED MURINE ANTIBODY FRAGMENT
3UBXI:108-214; L:108-214CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3UJTL:108-211; M:108-211STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O-ANTIGEN OF FRANCISELLA TULARENSIS
3V0VB:108-212; L:108-212FAB WN1 222-5 UNLIGANDED
3V0WL:108-211CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
3V6FB:115-219; D:115-219; F:115-219; L:115-219CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND
3V6OE:110-216; F:110-216LEPTIN RECEPTOR-ANTIBODY COMPLEX
3VFGL:108-214CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
3VG0L:110-215ANTIBODY FAB FRAGMENT
3VG9B:108-212CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
3VGAB:108-212CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
3VI3E:113-219; L:113-219CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3ZDXF:108-214; L:108-214INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3ZKMD:112-217; L:112-217BACE2 FAB COMPLEX
3ZKND:112-217; L:112-217BACE2 FAB INHIBITOR COMPLEX
4A6YL:111-211CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3-NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
4AEHL:108-212CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
4AEIL:113-218; M:113-217; N:113-217CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4AG4L:108-212CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4ALAL:108-212STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AMKL:111-212FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
4APQC:120-206CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
4AT6B:111-212; D:111-212; F:111-212; I:111-212; K:111-212; L:111-212; N:111-212; P:111-212FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4DGIL:108-213STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120-230
4DVBB:109-215; L:109-215THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4DW2L:108-214THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112
4EBQL:111-214FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
4EDXA:108-214; L:108-214NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
4EI5C:115-202CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4EI6A:115-203; B:116-243; C:115-202; D:116-243STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4ELKA:116-204; B:117-244; C:116-207; D:117-244CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
4ETQB:111-213; L:111-213VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4F15C:111-213; F:111-213; I:111-213; L:111-213MOLECULAR BASIS OF INFECTIVITY OF 2009 PANDEMIC H1N1 INFLUENZA A VIRUSES
4F2MB:108-213; D:108-211CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4F33A:107-212; C:107-212; E:107-212; G:107-212CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4F37K:113-218; L:113-218STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE
4F3FA:107-212CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4FFVC:107-210; L:107-210CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB
4FFWC:107-210; L:107-206CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4FG6D:107-211; F:107-211STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4GAYB:108-212; L:108-211STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4GMSL:108-211; N:108-213CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4GMTL:108-213; M:108-213CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
4GQ9L:110-212CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
4H20L:108-214CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18
4H88L:108-213STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120-230
4HC1L:108-213; N:108-213CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4HDIA:113-217; L:113-219CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4HLZH:110-213; J:110-214; L:110-214CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HXAL:108-214CRYSTAL STRUCTURE OF 13D9 FAB
4HXBL:108-214CRYSTAL STRUCTURE OF 6B9 FAB
4I9WD:107-211; F:107-211HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4IRSA:186-279; C:115-203; D:113-240STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
4J1UA:113-214; C:113-216; E:113-216CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
4JN1L:114-220AN ANTIDOTE FOR DABIGATRAN
4JN2A:114-220; L:114-220AN ANTIDOTE FOR DABIGATRAN
4JQIL:109-190STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
4JR9L:107-211CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
4JREC:107-211; L:107-211CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
4JZJB:114-219; L:114-219CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
4K23L:108-213STRUCTURE OF ANTI-UPAR FAB ATN-658
4K7PL:108-214GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4K9EL:111-227CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D
4KI5F:108-214CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4KJWD:107-211; F:107-211STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KK5D:107-211; F:107-211STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KK6D:107-211; F:107-211STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KK9D:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4KKAD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KKBD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KKCD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KPHL:108-212; M:108-210STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
4KQ4L:108-214CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
4KRPC:108-211NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4KUZL:113-216CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4KVCL:108-2122H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
4LEOB:114-219CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3)
4LEXL:113-217UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4LF3A:107-214; D:107-214INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR
4LVHC:111-210; F:111-210; I:111-210; L:111-210INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ
4M43L:108-213CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
4M61A:113-219; C:113-219CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
4M7JL:108-214CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
4M7KL:114-220CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
4M7ZC:108-214; L:108-213UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
4M93C:108-213; L:108-213UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
4MA1C:108-214; F:108-214; L:108-214UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
4MA7L:108-213CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
4MA8L:108-213CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
4MAUL:112-216CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4NCC1:107-210; L:107-211NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
(-)
Murinae, homo sapiens [TaxId: 39107] (2)
4GW1A:108-212; C:108-213CQFD MEDITOPE
4GW5A:108-212; C:108-213CQYN MEDITOPE - CETUXIMAB FAB
(-)
Rabbit (Oryctolagus cuniculus) [TaxId: 9986] (1)
4HT1L:112-217HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
(-)
Rhesus monkey (Macaca mulatta) [TaxId: 9544] (3)
3Q6GL:108-208; M:108-208CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4KTDL:108-208FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE136, FROM NON-HUMAN PRIMATE
4KTEL:108-208FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE148, FROM NON-HUMAN PRIMATE
(-)
Protein domain: beta2-microglobulin (530)
(-)
Cow (Bos taurus) [TaxId: 9913] (6)
1BMGA:CRYSTAL STRUCTURE OF BOVINE BETA2-MICROGLOBULIN
2XFXB:CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA
3L9RB:; D:; F:; H:CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
3PWVE:AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)
4F7CB:; D:CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
4F7EB:CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C16:0-ALPHA-GALACTOSYL CERAMIDE
(-)
Human (Homo sapiens) [TaxId: 9606] (350)
1A1MB:MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2
1A1NB:MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1
1A1OB:MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
1A6ZB:; D:HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
1A9BB:; E:DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1A9EB:DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1AGBB:ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)
1AGCB:ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)
1AGDB:ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)
1AGEB:ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)
1AGFB:ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)
1AKJB:COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
1AO7B:COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1B0GB:; E:CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX
1B0RB:CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
1BD2B:COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1C16B:; D:; F:; H:CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1CE6B:MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE
1CG9B:COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6
1DE4B:; E:; H:HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
1DUYB:; E:CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
1DUZB:; E:HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
1E27B:NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)
1E28B:NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)
1EEYB:; E:CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
1EEZB:; E:CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
1EFXB:STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1EXUB:CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
1GZPB:CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
1GZQB:CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
1HHGB:; E:THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHHB:THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHIB:; E:THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHJB:; E:THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHKB:; E:THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HLAM:STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
1HSAB:; E:THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1HSBB:DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE
1I1FB:; E:CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I1YB:; E:CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I4FB:CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1I7RB:; E:CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
1I7TB:; E:CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
1I7UB:; E:CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
1IM3B:; F:; J:; N:CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
1IM9B:; F:CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
1JF1B:CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
1JGDB:HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
1JGEB:HLA-B*2705 BOUND TO NONA-PEPTIDE M9
1JHTB:CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.
1JNJA:NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-MICROGLOBULIN
1K5NB:HLA-B*2709 BOUND TO NONA-PEPTIDE M9
1KPRB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1KTLB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1LDSA:CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2-MICROGLOBULIN
1LP9B:; I:XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1M05B:; D:HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1M6OB:CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE
1MHEB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1MI5B:THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1N2RB:A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.
1OF2B:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1OGAB:A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1OGTB:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1ONQB:; D:CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1P7QB:CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1PY4A:; B:; C:; D:BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS
1Q94B:; E:STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1QEWB:HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1QLFB:MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1QQDB:CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
1QR1B:; E:POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1QRNB:CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSEB:STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1QSFB:STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1QVOB:; E:STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1R3HB:; D:; F:; H:CRYSTAL STRUCTURE OF T10
1S8DB:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A
1S9WB:CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2
1S9XB:CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2
1S9YB:CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2
1SYSB:CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY
1SYVB:HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF
1T1WB:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V
1T1XB:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L
1T1YB:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V
1T1ZB:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A
1T20B:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I
1T21B:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL
1T22B:STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL
1TMCB:THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN
1TVBB:; E:CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
1TVHB:; E:CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
1UQSB:THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID
1UXSB:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS
1UXWB:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1VGKB:THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION
1W0VB:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
1W0WB:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
1W72B:; E:CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1X7QB:CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE
1XH3B:CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501
1XR8B:CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1XR9B:CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1XZ0B:; D:CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1YDPB:1.9A CRYSTAL STRUCTURE OF HLA-G
1YPZB:1-99; D:1-99IMMUNE RECEPTOR
1ZHKB:CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZHLB:CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZS8B:; D:; F:; H:; J:CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1ZSDB:CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY
1ZT4B:; D:THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE
1ZVSB:; E:CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
2A83B:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
2AK4B:; G:; L:; R:CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE
2AV1B:; E:CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
2AV7B:; E:CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
2AXFB:THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
2AXGB:THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
2BCKB:; E:CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
2BNQB:STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNRB:STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BSRB:CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BSSB:CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BSTB:CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BVOB:STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2BVPB:STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2BVQB:STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2C7UB:; E:CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
2CIIB:THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE
2CIKB:INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.
2CLRB:; E:THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
2D31B:1-99; E:1-99CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
2D4FA:THE CRYSTAL STRUCTURE OF HUMAN BETA2-MICROGLOBULIN
2DYPB:CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G
2ESVB:STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
2F53B:1-99DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2F54B:; G:DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2F74B:; E:MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
2F8OA:; B:A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY A BACKBONE TRIGGER
2FYYB:THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
2FZ3B:THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
2GITB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GJ6B:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GT9B:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART-1(26-35) PEPTIDE
2GTWB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
2GTZB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
2GUOB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE
2H26B:HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER
2H6PB:CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY
2HJKB:CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
2HJLB:CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
2HLAB:SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
2HN7B:HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE
2J8UB:; I:LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2JCCB:; I:AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2NW3B:CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2NX5B:; G:; L:; R:CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2P5EB:CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2P5WB:CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2PO6B:1-99; F:2-99CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2-MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2PYEB:CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2RFXB:CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF
2UWEB:; I:LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2V2WB:; E:T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
2V2XB:; E:T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
2VB5A:SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN
2VLJB:THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLKB:THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLLB:; E:THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLRB:; G:THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2X4NB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
2X4OB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
2X4PB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
2X4QB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
2X4RB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
2X4SB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
2X4TB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
2X4UB:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476
2X70B:; E:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
2XKSA:PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2YXFA:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF BETA2-MICROGLOBULIN UNDER PHYSIOLOGICAL CONDITIONS
2Z9TA:CRYSTAL STRUCTURE OF THE HUMAN BETA-2 MICROGLOBULIN MUTANT W60G
3B3IB:CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES
3B6SB:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
3BGMB:CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH8B:CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH9B:CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BHBB:CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BO8B:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE
3BP4B:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
3BP7B:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA
3BVNB:; E:HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
3BW9B:CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12-MER PEPTIDE FROM THE PP65 PROTEIN
3BWAB:CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8-MER PEPTIDE FROM THE PP65 PROTEIN
3BXNB:THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA
3BZEB:; D:; F:; H:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3C9NB:CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
3CDGB:0-99; D:0-99HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
3CIIB:0-99; E:0-99STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
3CIQA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD
3CZFB:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
3D18B:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS
3D25B:CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2
3D2UB:; F:STRUCTURE OF UL18, A PEPTIDE-BINDING VIRAL MHC MIMIC, BOUND TO A HOST INHIBITORY RECEPTOR
3D39B:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
3D3VB:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE
3DBXB:STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID
3DHJA:BETA 2 MICROGLOBULIN MUTANT W60C
3DHMA:BETA 2 MICROGLOBULIN MUTANT D59P
3DTXB:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
3DX6B:CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE
3DX7B:CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN
3DX8B:CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE
3EKCA:STRUCTURE OF W60V BETA-2 MICROGLOBULIN MUTANT
3FFCB:; G:CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
3FQNB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FQRB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FQTB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FQUB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FQWB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FQXB:PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
3FT2B:CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA-A2
3FT3B:CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2
3FT4B:CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2
3GIVB:; E:ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE
3GJFB:; E:RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GSNL:CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3GSOB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
3GSQB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
3GSRB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
3GSUB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
3GSVB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
3GSWB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
3GSXB:CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
3H7BB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE
3H9HB:; E:HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE
3H9SB:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
3HAEB:; E:; K:; Q:RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3HCVB:CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
3HLAB:HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1
3HPJB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE
3HUJB:; D:CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3I6GB:; E:NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201
3I6KB:; F:NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201
3I6LE:NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402
3IB4A:THE DOUBLE MUTANT OF BETA-2 MICROGLOBULIN K58P-W60G
3IXAB:; E:HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE
3JTTH:CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
3KLAB:; E:CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
3KPLB:CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPMB:CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPNB:CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPOB:CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPPB:CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPQB:CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPRB:; G:CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3KPSB:CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KWWB:CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE
3KYNB:CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE
3KYOB:; D:CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE
3L3DB:CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3GB:CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3IB:CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3JB:CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3KB:CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3LKNB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN
3LKOB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN
3LKPB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN
3LKQB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN
3LKRB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN
3LKSB:CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN
3LN4B:CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2
3LN5B:CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE
3LOWA:; B:CRYSTAL STRUCTURE OF BETA 2 MICROGLOBULIN DOMAIN-SWAPPED DIMER
3LV3B:CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)
3M17B:; D:; F:; H:CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
3M1BB:; D:; F:; H:CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
3MGOB:; E:; H:; K:CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
3MGTB:; E:; H:; K:CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
3MR9B:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT
3MRBB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT
3MRCB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT
3MRDB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT
3MREB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE
3MRFB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT
3MRGB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE
3MRHB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT
3MRIB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT
3MRJB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT
3MRKB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE
3MRLB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT
3MRMB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE
3MRNB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE
3MROB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRPB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRQB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRRB:CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE
3MV7B:CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
3MV8B:CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA-B*3501/HPVG
3MV9B:CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA-B*3501/HPVG
3MYJB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
3MYZA:; B:PROTEIN INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T
3MZTA:; B:; C:; D:; E:; F:PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T
3NA4A:D53P BETA-2 MICROGLOBULIN MUTANT
3O3AB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
3O3BB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
3O3DB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
3O3EB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
3O4LB:GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3OX8B:; E:CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
3OXRB:CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27
3OXSB:CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27
3PWJB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT
3PWLB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
3PWNB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
3PWPB:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3QDAA:CRYSTAL STRUCTURE OF W95L BETA-2 MICROGLOBULIN
3QDGB:THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJB:THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMB:THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEQB:THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QFDB:; E:HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
3QFJB:THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QZWB:; E:PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
3REWB:; E:CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3SDXB:; D:CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3T8XB:; D:CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
3TLRA:; B:; C:; D:CRYSTAL STRUCTURE OF THE TETRAMERIC BETA-2 MICROGLOBULIN DIMC20 MUTANT
3TM6A:; B:; C:; D:; E:; F:; G:; H:CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT
3TZVD:CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U0PB:; D:; F:CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
3UPRB:; D:HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
3UTQB:HUMAN HLA-A*0201-ALWGPDPAAA
3UTSB:; G:1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC
3UTTB:; G:1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC
3VH8B:; E:KIR3DL1 IN COMPLEX WITH HLA-B*5701
3VWJB:TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKB:TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
4EN3B:118-242; D:CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4FXLA:CRYSTAL STRUCTURE OF THE D76N BETA-2 MICROGLOBULIN MUTANT
4K71C:; F:CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
4KDTC:; D:STRUCTURE OF AN EARLY NATIVE-LIKE INTERMEDIATE OF BETA2-MICROGLOBULIN AMYLOIDOSIS
4L29B:; D:; F:; H:; J:; L:; N:; P:; R:; T:; V:; X:; Z:STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
4L3CB:; D:; F:; H:; J:; L:; N:; P:; R:; T:; V:; X:; Z:STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
4L4TB:; F:STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VB:; F:STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4LCWB:; F:THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LHUB:CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4N0FB:; F:; I:; L:HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
(-)
Mouse (Mus musculus) [TaxId: 10090] (166)
1BIIB:THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110
1BQHB:; E:MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
1BZ9B:CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027
1CD1B:; D:CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1DDHB:MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
1FFNB:; E:CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1FFOB:; E:CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1FFPB:; E:CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1FG2B:; E:; H:; K:CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1FO0L:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1FZJB:MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1FZKB:MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1FZMB:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1FZOB:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1G6RL:; M:A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1G7PB:CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1G7QB:CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA
1HOCB:THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION
1INQB:STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A, COMPLEXED TO H2-DB
1JPFB:CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JPGB:CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JUFB:STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB
1K8DB:CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE
1KBGL:MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2
1KJ2L:; M:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1KJ3L:; M:MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
1KPUB:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/VSV8
1KPVB:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/SEV9
1LD9B:; E:THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1LDPL:CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1LEGB:CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE
1LEKB:CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8
1LK2B:1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE
1MHCB:; E:MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1MWAL:; M:2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1N3NB:; D:; F:; H:CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1N59B:; D:CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1N5AB:; E:; H:; K:CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1NAML:MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1NANI:; P:MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
1NEZB:THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY
1OSZB:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1P1ZB:X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB
1P4LB:CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB
1PQZB:MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144
1QO3B:COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
1RJYB:; E:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RJZB:; E:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1RK0B:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RK1B:MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1S7QB:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7RB:; E:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7SB:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7TB:; E:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7UB:; E:; H:; K:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7VB:; E:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7WB:; E:; H:; K:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7XB:; E:; H:; K:CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1T0MB:; E:CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1T0NB:; E:CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1U58B:CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144
1VACB:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
1VADB:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1WBXB:CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBYB:CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBZB:; D:CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1YN6B:CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE
1YN7B:CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE
1Z5LB:; D:STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1ZHBB:; E:; H:; K:CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA-MONOOXIGENASE
1ZHNB:CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE
1ZT1B:CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE
1ZT7B:1-99; D:1-99CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
2AKRB:; D:STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
2CKBL:; M:STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2CLVB:; P:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
2CLZB:; P:MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
2FIKB:STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D
2FO4B:ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE
2FWOB:MHC CLASS I H-2KD HEAVY CHAIN IN COMPLEX WITH BETA-2MICROGLOBULIN AND PEPTIDE DERIVED FROM INFLUENZA NUCLEOPROTEIN
2GAZB:MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D
2MHAB:; D:CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
2OL3L:CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2Q7YB:; D:STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
2VAAB:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
2VABB:MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
2VE6B:; E:; H:; K:CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
2ZOKB:; D:; F:; H:CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
2ZOLB:; D:CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
2ZSVB:; D:CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
2ZSWB:; D:; F:; H:CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
3ARBB:TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3ARDB:TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3AREB:TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3ARFB:TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3ARGB:TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2)
3AU1B:CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3
3BUYB:MHC-I IN COMPLEX WITH PEPTIDE
3C8KB:THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB
3CC5B:; E:H-2DB COMPLEX WITH HUMAN GP100
3CCHB:; E:; H:; K:H-2DB COMPLEX WITH MURINE GP100
3CH1B:; E:; H:; K:CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
3CPLB:; D:CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
3CVHB:; N:HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3DMMB:CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX
3E6FB:MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PA9, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3E6HB:MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3ECBB:CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
3FOLB:CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI
3FOMB:CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL
3FONB:; D:CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
3FTGB:CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA
3G08B:CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
3GMLB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH
3GMMB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH
3GMNB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH
3GMOB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF
3GMPB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25
3GMQB:STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED
3GMRB:STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP
3HE6B:CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3HE7B:CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
3ILPB:STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
3ILQD:STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
3L3HB:X-RAY CRYSTAL STRUCTURE OF THE F6A MUTANT OF INFLUENZA A ACID POLYMERASE EPITOPE PA224 BOUND TO MURINE H2-DB MHC
3MA7B:; D:CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
3O8XB:RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WB:RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3P4MB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV
3P4NB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV
3P4OB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL, AN 8-MER MODIFIED PEPTIDE FROM THE LCMV
3P9LB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA
3P9MB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4
3PABB:; E:CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
3PWUB:AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11)
3QI9B:CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3QUXB:STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYB:STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZB:STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3RGVD:A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3RTQB:STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3RUGB:; D:CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2)
3RZCB:STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3SCMB:CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3SDAB:CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDCB:CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
3SDDB:CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
3T1FB:CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX
3TA3B:STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3TO4B:STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TVMB:; F:STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3UBXB:; E:CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
4APQB:CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
4EI5B:; F:CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4HUUB:; E:CRYSTAL STRUCTURE OF H2DB-NPM6I
4HUVB:; E:CRYSTAL STRUCTURE OF H2DB-NPM6W
4HUWB:; D:; F:; H:CRYSTAL STRUCTURE OF H2DB-NPM6T
4HUXB:CRYSTAL STRUCTURE OF H2DB-H155A-NP
4HV8B:; D:CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
4IRJB:STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4IRSB:STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
4L8BB:CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5H PEPTIDE
4L8CB:; D:; F:; H:CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
4L8DB:; D:CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
4MNGB:; D:STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MQ7B:STRUCTURE OF HUMAN CD1D-SULFATIDE
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (6)
1ED3B:; E:CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
1FRTB:CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1I1AB:CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1KJMB:TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE
1KJVB:TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE
3FRUB:; D:; F:NEONATAL FC RECEPTOR, PH 6.5
(-)
Pig (Sus scrofa) [TaxId: 9823] (2)
3QQ3B:; E:CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
3QQ4B:CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
(-)
Protein domain: CD1, alpha-3 domain (24)
(-)
Cow (Bos taurus) [TaxId: 9913] (2)
4F7CA:184-279; C:184-279CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
4F7EA:184-278CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C16:0-ALPHA-GALACTOSYL CERAMIDE
(-)
Human (Homo sapiens), CD1a [TaxId: 9606] (5)
1ONQA:184-280; C:184-279CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
3HUJA:184-280; C:184-278CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3U0PA:184-278; C:184-279; E:184-277CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
3VWKA:184-277TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
4EN3C:184-277CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
(-)
Human (Homo sapiens), CD1b [TaxId: 9606] (6)
1GZPA:184-280CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
1GZQA:184-280CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
1UQSA:184-283THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID
1XZ0A:184-277; C:184-277CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
2H26A:184-905HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER
3T8XA:184-278; C:184-282CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
(-)
Human (Homo sapiens), CD1d [TaxId: 9606] (2)
1ZT4A:184-277THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE
2PO6A:184-277; E:184-277CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2-MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
(-)
Mouse (Mus musculus) [TaxId: 10090] (9)
1CD1A:186-279; C:186-279CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
2AKRA:186-279; C:186-279STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
2GAZA:186-279MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D
2Q7YA:186-279; C:186-279STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
3ARBA:186-302TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3AREA:186-300TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3ARFA:186-300TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3QI9A:186-295CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3SCMA:186-295CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
(-)
Protein domain: Class I MHC homolog, alpha-3 domain (6)
(-)
Human (Homo sapiens), Mic-a [TaxId: 9606] (2)
1B3JA:181-274STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A, A GAMMADELTA T CELL LIGAND
1HYRC:181-274CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D
(-)
Human (Homo sapiens), Mic-b [TaxId: 9606] (1)
1JE6A:181-274STRUCTURE OF THE MHC CLASS I HOMOLOG MICB
(-)
Mouse (Mus musculus), t10 [TaxId: 10090] (1)
1R3HA:1181-1276; C:3181-3276; E:5181-5273; G:7181-7274CRYSTAL STRUCTURE OF T10
(-)
Mouse (Mus musculus), t22 [TaxId: 10090] (2)
1C16A:181-276; C:181-276; E:181-276; G:181-276CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1YPZA:181-276; C:181-276IMMUNE RECEPTOR
(-)
Protein domain: Class I MHC, alpha-3 domain (293)
(-)
Human (Homo sapiens) [TaxId: 9606] (187)
1A1MA:182-278MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2
1A1NA:182-276MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1
1A1OA:182-276MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
1A9BA:182-277; D:182-277DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1A9EA:182-277DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1AGBA:182-276ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)
1AGCA:182-276ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)
1AGDA:182-276ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)
1AGEA:182-276ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)
1AGFA:182-276ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)
1AKJA:182-276COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
1AO7A:182-274COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1B0GA:182-275; D:182-275CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX
1B0RA:182-275CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
1BD2A:182-275COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1CG9A:182-277COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6
1DUYA:182-275; D:182-275CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
1DUZA:182-275; D:182-275HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
1E27A:182-276NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)
1E28A:182-276NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)
1EEYA:182-275; D:182-275CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
1EEZA:182-275; D:182-275CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
1EFXA:182-278STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1HHGA:182-275; D:182-275THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHHA:182-275THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHIA:182-275; D:182-275THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHJA:182-275; D:182-275THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHKA:182-275; D:182-275THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HLAA:182-270STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
1HSAA:182-276; D:182-276THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1HSBA:182-270DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE
1I1FA:182-275; D:182-275CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I1YA:182-275; D:182-275CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I4FA:182-275CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1I7RA:182-275; D:182-275CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
1I7TA:182-275; D:182-275CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
1I7UA:182-275; D:182-275CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
1IM3A:182-275; E:182-275; I:182-275; M:182-275CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
1IM9A:182-275; E:182-275CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
1JF1A:182-275CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
1JGDA:182-276HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
1JGEA:182-276HLA-B*2705 BOUND TO NONA-PEPTIDE M9
1JHTA:182-275CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.
1K5NA:182-276HLA-B*2709 BOUND TO NONA-PEPTIDE M9
1KPRA:182-274; C:182-274THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1KTLA:182-274; C:182-274THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1LP9A:182-275; H:182-275XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1M05A:182-277; C:182-277HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1M6OA:182-276CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE
1MHEA:182-274; C:182-274THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1MI5A:182-277THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1N2RA:182-276A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.
1OF2A:182-276CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1OGAA:182-276A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1OGTA:182-276CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1P7QA:182-276CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1Q94A:182-275; D:182-275STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1QEWA:182-275HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1QQDA:182-274CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
1QR1A:182-275; D:182-275POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1QRNA:182-274CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSEA:182-274STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1QSFA:182-274STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1QVOA:182-275; D:182-275STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1S8DA:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A
1S9WA:182-274CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2
1S9XA:182-274CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2
1S9YA:182-274CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2
1SYSA:182-276CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY
1SYVA:182-276HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF
1T1WA:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V
1T1XA:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L
1T1YA:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V
1T1ZA:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A
1T20A:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I
1T21A:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL
1T22A:182-275STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL
1TVBA:182-275; D:182-275CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
1TVHA:182-275; D:182-275CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
1UXSA:182-276CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS
1UXWA:182-276CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1W0VA:182-276CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
1W0WA:182-276CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
1W72A:182-274; D:182-274CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1X7QA:182-275CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE
1XH3A:182-276CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501
1XR8A:182-276CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1XR9A:182-276CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1YDPA:183-2761.9A CRYSTAL STRUCTURE OF HLA-G
1ZHKA:182-276CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZHLA:182-276CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZSDA:182-276CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY
2A83A:182-276CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
2AK4A:182-276; F:182-276; K:182-276; Q:182-276CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE
2AV1A:182-275; D:182-275CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
2AV7A:182-275; D:182-275CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
2AXFA:182-276THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
2AXGA:182-276THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
2BCKA:182-276; D:182-276CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
2BNQA:182-276STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNRA:182-276STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BSRA:182-276CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BSSA:182-276CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BSTA:182-276CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
2BVOA:182-275STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2BVPA:182-274STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2BVQA:182-275STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
2C7UA:182-275; D:182-275CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
2CIKA:182-276INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.
2CLRA:182-275; D:182-275THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
2D31A:182-274; D:182-274CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
2DYPA:182-276CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G
2ESVA:182-274STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
2F53A:182-275DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2F54A:182-274; F:182-274DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2FYYA:182-276THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
2FZ3A:182-276THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
2GITA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GJ6A:182-275THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GT9A:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART-1(26-35) PEPTIDE
2GTWA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
2GTZA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
2GUOA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE
2H6PA:182-276CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY
2HJKA:182-274CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
2HJLA:182-274CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
2HLAA:182-270SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
2HN7A:182-274HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE
2J8UA:182-275; H:182-275LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2JCCA:182-275; H:182-275AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2NW3A:182-276CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2NX5A:182-276; F:182-276; K:182-276; Q:182-276CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2P5EA:182-276CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2P5WA:182-276CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2PYEA:182-276CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2RFXA:182-275CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF
2UWEA:182-275; H:182-275LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2V2WA:182-276; D:182-276T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
2V2XA:182-276; D:182-276T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
2VLJA:182-276THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLKA:182-276THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLLA:182-276; D:182-276THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLRA:182-276; F:182-276THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
3B3IA:182-276CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES
3B6SA:182-276CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
3BGMA:182-274CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH8A:182-274CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH9A:182-275CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BHBA:182-274CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BZEA:182-274; C:182-274; E:182-274; G:182-274THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3BZFA:182-274; C:182-274THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3C9NA:182-276CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
3CDGA:182-274; C:182-274HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
3CIIA:182-274; D:182-274STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
3HLAA:182-270HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1
3KPLA:182-276CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPMA:182-276CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPNA:182-276CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPOA:182-276CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPPA:182-276CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPQA:182-276CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPRA:182-276; F:182-276CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3KPSA:182-276CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3LKNA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN
3LKOA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN
3LKPA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN
3LKQA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN
3LKRA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN
3LKSA:182-276CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN
3O3AA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
3O3BA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
3O3DA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
3O3EA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
3O4LA:182-276GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3PWJA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT
3PWLA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
3PWNA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
3PWPA:182-275THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3QDGA:182-275THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJA:182-275THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMA:182-275THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEQA:182-275THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QFDA:182-275; D:182-275HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
3QFJA:182-275THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3UPRA:182-276; C:182-276HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
4L29A:182-276; C:182-276; E:182-276; G:182-276; I:182-276; K:182-276; M:182-276; O:182-276; Q:182-276; S:182-276; U:182-276; W:182-276; Y:182-276STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
4L3CA:182-276; C:182-276; E:182-276; G:182-276; I:182-276; K:182-276; M:182-276; O:182-276; Q:182-276; S:182-276; U:182-276; W:182-276; Y:182-276STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
(-)
Mouse (Mus musculus) [TaxId: 10090] (102)
1BIIA:182-274THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110
1BQHA:182-274; D:182-274MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
1BZ9A:182-274CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027
1CE6A:182-274MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE
1DDHA:182-274MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
1FFNA:182-274; D:182-274CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1FFOA:182-274; D:182-274CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1FFPA:182-274; D:182-274CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1FG2A:182-274; D:182-274; G:182-274; J:182-274CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1FO0H:182-275MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1FZJA:182-274MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1FZKA:182-274MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1FZMA:182-274MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1FZOA:182-274MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1G6RH:182-274; I:182-274A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1G7PA:182-274CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1G7QA:182-274CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA
1HOCA:182-272THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION
1INQA:182-275STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A, COMPLEXED TO H2-DB
1JPFA:182-276CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JPGA:182-276CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JUFA:182-276STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB
1K8DA:182-274CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE
1KBGH:182-274MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2
1KJ2H:182-276; I:182-277MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1KJ3H:182-278; I:182-278MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
1KPUA:182-274HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/VSV8
1KPVA:182-274HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/SEV9
1LD9A:182-268; D:182-268THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1LDPH:182-272CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1LEGA:182-274CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE
1LEKA:182-274CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8
1LK2A:182-2741.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE
1MHCA:182-276; D:182-276MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1MWAH:182-274; I:182-2742C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1N3NA:182-276; C:182-276; E:182-276; G:182-276CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1N59A:182-276; C:182-276CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1N5AA:182-276; D:182-274; G:182-274; J:182-274CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1NAMH:182-275MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1NANH:182-278; L:182-278MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
1NEZA:182-274THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY
1OSZA:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1P1ZA:182-274X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB
1P4LA:182-274CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB
1QLFA:182-276MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1QO3A:182-275COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
1RJYA:182-278; D:182-278MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RJZA:182-278; D:182-278MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1RK0A:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RK1A:182-274MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1S7QA:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7RA:182-276; D:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7SA:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7TA:182-276; D:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7UA:182-276; D:182-274; G:182-274; J:182-274CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7VA:182-276; D:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7WA:182-276; D:182-276; G:182-276; J:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7XA:182-276; D:182-276; G:182-276; J:182-276CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1T0MA:182-278; D:182-278CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1T0NA:182-278; D:182-278CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1VACA:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
1VADA:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1VGKA:182-274THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION
1WBXA:182-274CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBYA:182-274CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBZA:182-274; C:182-274CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1YN6A:182-274CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE
1YN7A:182-274CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE
1ZHBA:182-274; J:182-274; D:182-274; G:182-274CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA-MONOOXIGENASE
1ZS8A:181-274; C:181-274; E:181-274; G:181-274; I:181-274CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1ZT1A:181-276CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE
1ZT7A:181-275; C:181-275CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
2CIIA:182-274THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE
2CKBH:182-274; I:182-274STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2CLVA:182-274; H:182-274MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
2CLZA:182-274; H:182-274MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
2F74A:182-274; D:182-274MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
2FO4A:182-274ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE
2FWOA:182-275MHC CLASS I H-2KD HEAVY CHAIN IN COMPLEX WITH BETA-2MICROGLOBULIN AND PEPTIDE DERIVED FROM INFLUENZA NUCLEOPROTEIN
2MHAA:182-270; C:182-270CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
2OL3H:182-274CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2VAAA:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
2VABA:182-274MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
2VE6A:182-274; D:182-274; G:182-274; J:182-274CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
2ZOKA:182-274; C:182-274; E:182-274; G:182-274CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
2ZOLA:182-274; C:182-274CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
3BUYA:182-276MHC-I IN COMPLEX WITH PEPTIDE
3C8KA:182-274THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB
3CH1A:182-276; D:182-276; G:182-276; J:182-276CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
3CVHA:182-274; M:182-274HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3E6FA:182-274MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PA9, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3E6HA:182-275MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
3FTGA:182-275CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA
3RGVC:182-275A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
4HUUA:182-278; D:182-277CRYSTAL STRUCTURE OF H2DB-NPM6I
4HUVA:182-275; D:182-275CRYSTAL STRUCTURE OF H2DB-NPM6W
4HUWA:182-277; C:182-277; E:182-277; G:182-277CRYSTAL STRUCTURE OF H2DB-NPM6T
4HUXA:182-276CRYSTAL STRUCTURE OF H2DB-H155A-NP
4HV8A:182-277; C:182-278CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
4L8BA:182-276CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5H PEPTIDE
4L8CA:182-275; C:182-275; E:182-275; G:182-275CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
4L8DA:182-277; C:182-277CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
(-)
Norway rat (Rattus norvegicus), RT1-AA [TaxId: 10116] (3)
1ED3A:182-275; D:182-275CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
1KJMA:182-277TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE
1KJVA:182-276TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE
(-)
Rhesus monkey (Macaca mulatta) [TaxId: 9544] (1)
1ZVSA:182-278; D:182-278CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
(-)
Protein domain: Class II MHC alpha chain, C-terminal domain (75)
(-)
Human (Homo sapiens), HLA-DM [TaxId: 9606] (1)
1HDMA:94-196HISTOCOMPATIBILITY ANTIGEN HLA-DM
(-)
Human (Homo sapiens), HLA-DQ group [TaxId: 9606] (3)
1JK8A:85-181CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
1S9VA:85-180; D:85-178CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
1UVQA:85-183CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
(-)
Human (Homo sapiens), HLA-DR group [TaxId: 9606] (37)
1A6AA:82-180THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
1AQDA:82-181; D:82-179; G:82-179; J:82-179HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1BX2A:82-181; D:82-181CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
1D5MA:82-181X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
1D5XA:82-181X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
1D5ZA:82-180X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
1D6EA:82-180CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
1DLHA:82-182; D:82-182CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
1FV1A:82-181; D:82-181STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
1FYTA:82-181CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1
1H15A:82-182; D:82-182X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
1HQRA:82-181CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH-AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II
1HXYA:82-182CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
1J8HA:82-181CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4
1JWMA:82-182CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3
1JWSA:82-182CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
1JWUA:82-182CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
1KG0A:82-182STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
1KLGA:82-180CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1KLUA:82-182CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1LO5A:82-182CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
1PYWA:82-182HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ, FVKQNA(MAA)AL, IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1R5IA:82-181; E:82-181CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
1SEBA:82-181; E:82-181COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1SJEA:82-181HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
1SJHA:82-181HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
1T5WA:82-181; D:82-181HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
1T5XA:82-181HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
2IAMA:82-181STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IANA:82-181; F:82-181; K:82-181; P:82-181STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2SEBA:82-180X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
3C5JA:82-180CRYSTAL STRUCTURE OF HLA DR52C
3O6FA:82-181; E:82-180CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
4E41A:82-181; F:82-181STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4H25A:82-182; D:82-182TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
4H26A:82-181; D:82-181TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
4I5BA:82-181; D:82-188STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
(-)
Mouse (Mus musculus), H2-DM [TaxId: 10090] (1)
1K8IA:93-191CRYSTAL STRUCTURE OF MOUSE H2-DM
(-)
Mouse (Mus musculus), I-A group [TaxId: 10090] (24)
1D9KC:82-182; G:82-182CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1ES0A:83-180CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
1F3JA:83-181; D:83-181HISTOCOMPATIBILITY ANTIGEN I-AG7
1IAKA:82-181HISTOCOMPATIBILITY ANTIGEN I-AK
1IAOA:83-178CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
1JL4A:82-181CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1K2DA:82-181CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
1LNUA:84-182; C:84-182; E:84-182; G:84-182CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
1MUJA:84-183CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
1U3HC:82-181; G:82-181CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
1YMMA:83-179TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
1ZGLA:83-179; D:83-179; G:83-179; J:83-179CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2G9HA:83-179CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE
2IADA:83-186CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
2ICWA:83-179; D:83-179CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE
2IPKA:83-179CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE, ACPKXVKQNTLKLAT (X=3-[5-(DIMETHYLAMINO)-1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL]-L-ALANINE) AND THE SUPERANTIGEN, SEC3 VARIANT 3B2
2OJEA:83-179; E:83-179MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
2P24A:82-181I-AU/MBP125-135
2PXYC:82-180CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2Z31C:82-180CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
3C5ZC:84-182; G:84-182CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3C60C:83-182; G:83-182CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3C6LC:83-182; G:83-182CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
3CUPA:84-181CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235
(-)
Mouse (Mus musculus), I-E group [TaxId: 10090] (9)
1FNEA:82-182; C:82-182HISTOCOMPATIBILITY ANTIGEN
1FNGA:82-182; C:82-182HISTOCOMPATIBILITY ANTIGEN
1I3RA:82-182; E:82-182; G:82-182; C:82-182CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1IEAA:82-182; C:82-182HISTOCOMPATIBILITY ANTIGEN
1IEBA:82-182; C:82-182HISTOCOMPATIBILITY ANTIGEN
1KT2A:82-182; C:82-182CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1KTDA:82-182; C:82-182CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1R5VA:82-182; C:82-182EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1R5WA:82-182; C:82-182EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
(-)
Protein domain: Class II MHC beta chain, C-terminal domain (70)
(-)
Human (Homo sapiens), HLA-DM [TaxId: 9606] (1)
1HDMB:88-185HISTOCOMPATIBILITY ANTIGEN HLA-DM
(-)
Human (Homo sapiens), HLA-DQ group [TaxId: 9606] (3)
1JK8B:95-192CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
1S9VB:95-190; E:95-190CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
1UVQB:95-191CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
(-)
Human (Homo sapiens), HLA-DR group [TaxId: 9606] (40)
1A6AB:93-191THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
1AQDB:93-190; E:93-190; H:93-190; K:93-191HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1BX2B:93-193; E:93-191CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
1D5MB:93-190X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
1D5XB:93-190X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
1D5ZB:93-190X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
1D6EB:93-190CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
1DLHB:93-190; E:93-190CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
1FV1B:93-190; E:93-190STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
1FYTB:93-190CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1
1H15B:93-190; E:93-190X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
1HQRB:293-390CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH-AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II
1HXYB:93-190CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
1J8HB:93-190CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4
1JWMB:93-190CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3
1JWSB:93-190CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
1JWUB:93-190CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
1KG0B:93-190STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
1KLGB:93-190CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1KLUB:93-190CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1LO5B:93-190CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
1PYWB:93-190HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ, FVKQNA(MAA)AL, IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1R5IB:93-190; F:93-190CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
1SEBB:93-192; F:93-192COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1SJEB:93-190HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
1SJHB:93-190HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
1T5WB:93-190; E:93-190HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
1T5XB:93-190HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
1YMMB:93-189TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
1ZGLB:93-189; E:93-189; H:93-189; K:93-189CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2G9HB:93-190CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE
2IAMB:93-190STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IANB:93-190; G:93-190; L:93-190; Q:93-190STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2ICWB:93-190; E:93-190CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE
2IPKB:93-190CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE, ACPKXVKQNTLKLAT (X=3-[5-(DIMETHYLAMINO)-1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL]-L-ALANINE) AND THE SUPERANTIGEN, SEC3 VARIANT 3B2
2NNAB:93-190STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DQ8 BOUND WITH A DEAMIDATED GLUTEN PEPTIDE
2OJEB:93-190; F:93-190MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
2SEBB:93-190X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
4E41B:93-190; G:93-190STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4I5BB:93-193; E:93-191STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
(-)
Mouse (Mus musculus), H2-DM [TaxId: 10090] (1)
1K8IB:95-190CRYSTAL STRUCTURE OF MOUSE H2-DM
(-)
Mouse (Mus musculus), I-A group [TaxId: 10090] (16)
1D9KD:93-190; H:93-190CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1ES0B:94-189CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
1F3JB:94-191; E:94-191HISTOCOMPATIBILITY ANTIGEN I-AG7
1IAKB:93-190HISTOCOMPATIBILITY ANTIGEN I-AK
1IAOB:94-188CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
1JL4B:93-190CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1K2DB:93-190CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
1LNUB:121-217; H:121-217; D:121-217; F:121-217CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
1MUJB:94-192CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
1U3HD:93-190; H:93-190CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2IADB:94-190CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
2PXYD:94-191CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2Z31D:94-190CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
3C5ZD:121-217; H:121-217CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3C60D:121-217; H:121-217CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3C6LD:121-217; H:121-217CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
(-)
Mouse (Mus musculus), I-E group [TaxId: 10090] (9)
1FNEB:93-188; D:93-188HISTOCOMPATIBILITY ANTIGEN
1FNGB:93-188; D:93-188HISTOCOMPATIBILITY ANTIGEN
1I3RB:121-216; F:121-216; H:121-216; D:121-216CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1IEAB:93-188; D:93-188HISTOCOMPATIBILITY ANTIGEN
1IEBB:93-188; D:93-188HISTOCOMPATIBILITY ANTIGEN
1KT2B:121-215; D:121-215CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1KTDB:121-215; D:121-215CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1R5VB:121-215; D:121-215EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
1R5WB:121-215; D:121-215EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
(-)
Protein domain: Fc (IgG) receptor, alpha-3 domain (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1EXUA:177-267CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (3)
1FRTA:179-269CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1I1AA:179-269CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
3FRUA:179-269; C:179-269; E:179-269NEONATAL FC RECEPTOR, PH 6.5
(-)
Protein domain: Hemochromatosis protein Hfe, alpha-3 domain (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1A6ZA:182-275; C:182-275HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
1DE4A:182-275; D:182-275; G:182-275HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
(-)
Protein domain: Immunoglobulin heavy chain alpha constant domain 1, CH1-alpha (3)
(-)
Mouse (Mus musculus) [TaxId: 10090] (3)
1MCPH:122-222PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
2FBJH:119-220REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
2MCPH:122-222REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
(-)
Protein domain: Immunoglobulin heavy chain alpha constant domain 2, CH2-alpha (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1OW0A:242-342; B:242-342CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC
2QEJA:242-342; B:242-342CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
(-)
Protein domain: Immunoglobulin heavy chain alpha constant domain 3, CH3-alpha (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1OW0A:343-450; B:343-450CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC
2QEJA:343-450; B:343-450CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
(-)
Protein domain: Immunoglobulin heavy chain epsilon constant domain 2, CH2-epsilon (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1G84A:THE SOLUTION STRUCTURE OF THE C EPSILON2 DOMAIN FROM IGE
1O0VA:228-330; B:228-330THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION
(-)
Protein domain: Immunoglobulin heavy chain epsilon constant domain 3, CH3-epsilon (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1F6AB:328-438; D:329-438STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)
1FP5A:336-438CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3-CEPSILON4 FRAGMENT.
1O0VA:331-438; B:331-438THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION
(-)
Protein domain: Immunoglobulin heavy chain epsilon constant domain 4, CH4-epsilon (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1F6AB:439-544; D:439-544STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)
1FP5A:439-543CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3-CEPSILON4 FRAGMENT.
1O0VA:439-545; B:439-546THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION
(-)
Protein domain: Immunoglobulin heavy chain gamma constant domain 1, CH1-gamma (608)
(-)
Chinese hamster (Cricetulus griseus) [TaxId: 10029] (1)
1NFDF:115-228; H:115-228AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
(-)
Human (Homo sapiens) [TaxId: 9606] (179)
1A4JB:120-217; H:120-217DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1A4KB:120-213; H:120-211DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1AD0B:114-211; D:114-211FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
1AD9B:114-212; H:114-212IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
1AJ7H:115-216IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
1AQKH:124-226THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
1AXSB:114-214; H:114-214MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1B2WH:118-220COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1B4JH:118-220COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
1BBJB:116-212; H:116-212CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
1BEYH:122-219ANTIBODY TO CAMPATH-1H HUMANIZED FAB
1BJ1H:124-224; K:124-224VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1BZ7B:123-217FAB FRAGMENT FROM MURINE ASCITES
1C5BH:114-230DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM
1C5CH:114-230DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX
1CE1H:122-2201.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
1CLYH:114-227IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1CZ8H:124-224; Y:124-224VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1D5BB:114-214; H:114-214UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
1D5IH:114-214UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
1D6VH:114-214CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
1DFBH:127-229STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I
1FL5B:114-213; H:114-213THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
1FL6B:114-213; H:114-213THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
1FVDB:121-223; D:121-223X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1FVEB:121-223; D:121-223X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
1G9MH:130-229HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9NH:130-229HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1GAFH:115-21748G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1GC1H:130-229HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1HKLH:115-216FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1HZHH:114-235; K:114-235CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1I7ZB:114-228; D:114-228ANTIBODY GNC92H2 BOUND TO LIGAND
1I9RH:119-219; K:119-219; X:119-219STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
1IQDB:115-212HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB.
1IT9H:122-219CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
1JPSH:118-217CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
1JPTH:118-217CRYSTAL STRUCTURE OF FAB D3H44
1L7IH:114-216CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
1MCOH:118-219THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
1MHPH:119-219CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
1MIMH:116-215IGG FAB FRAGMENT (CD25-BINDING)
1N0XH:114-228; K:114-230CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
1N7ML:115-216GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1N8ZB:121-220CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
1NGWB:115-216; H:115-216CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
1NGXB:115-216; H:115-216CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
1NGYB:115-216CHIMERIC MATURE FAB 7G12-APO
1NGZB:115-220CHIMERIC GERMLINE FAB 7G12-APO
1NL0H:114-217CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12
1OM3H:116-228; K:116-229FAB 2G12 UNLIGANDED
1OP3H:116-228; M:116-228CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
1OP5H:116-229; M:116-229CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
1PG7H:118-213; I:118-213MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1PKQB:114-216; G:114-213MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
1Q1JH:114-227; I:114-227CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
1RHHB:114-216; D:114-216CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1RZ7H:114-213CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D
1RZ8B:114-213; D:114-213CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
1RZFH:114-214CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
1RZGA:114-214; C:114-213CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1RZIB:114-213; D:114-213; F:114-214; H:114-213; J:114-213; L:114-213; N:114-213; P:114-213CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
1RZJH:114-214HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZKH:114-214HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1S3KH:120-219CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
1S78D:114-216; F:114-216INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX
1T04B:119-219; D:119-219THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
1T3FB:119-219THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
1TJGH:114-216CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
1TJHH:114-216CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
1TJIH:114-216CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
1TZGH:114-232; I:114-228CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1TZHB:114-213; H:114-213CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
1TZIB:114-213CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
1U6AH:114-213CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1U8HB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
1U8IB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
1U8JB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
1U8KB:114-215CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
1U8LB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
1U8MB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
1U8NB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
1U8OB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
1U8PB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
1U8QB:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
1U91B:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW-[DAP]-S (CYCLIC)
1U92B:114-215CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]-DKWQS (CYCLIC)
1U93B:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW-[DAP]-S (CYCLIC)
1U95B:114-216CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
1UCBH:114-227STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ)
1UJ3B:418-517CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
1UM4H:120-219CATALYTIC ANTIBODY 21H3 WITH HAPTEN
1UM5H:120-219CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
1UM6H:120-219CATALYTIC ANTIBODY 21H3
1UWEH:114-216; V:114-216; Y:114-216MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1UWGH:114-215; Y:114-215MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1VGEH:123-225TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
1W72H:114-228; I:114-228CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1Y0LB:114-233; D:114-233; F:114-233; H:114-233CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
1Y18B:114-233; D:114-233; F:114-233; H:114-233FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
1YYLH:114-214; R:1114-1214CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
1YYMH:114-214; R:1114-1214CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
1ZA3B:114-214; H:114-214THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1ZA6B:116-218; D:116-218; F:116-218; H:116-218THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSH:114-227FAB 2G12 + MAN4
1ZLUH:114-227; M:114-227FAB 2G12 + MAN5
1ZLVH:114-227; M:114-227FAB 2G12 + MAN7
1ZLWH:114-227; M:114-227FAB 2G12 + MAN8
2B0SH:114-229CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
2B1AH:114-229CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2B1HH:114-229CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2B4CH:114-212CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2DD8H:114-216CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY
2F5AH:133-232CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
2F5BH:133-235CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
2FB4H:120-221DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2FGWH:125-228X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
2FJFB:121-223; D:121-223; F:121-223; H:121-223; I:121-223; K:121-223; N:121-223; P:121-223; R:121-223; T:121-223; V:121-223; X:121-223STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGB:121-223; H:121-223STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FX7H:114-228CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX8H:114-227; I:114-227; J:114-227; K:114-227CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2FX9H:114-227; I:114-227CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
2G75A:114-214; C:114-214CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY
2H9GB:114-213; H:114-213CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFB:114-214; H:114-213CRYSTAL STRUCTURE OF CB2 FAB
2HFGH:114-214CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2HH0H:152-271STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
2I5YH:114-214; R:114-214CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2I60H:114-214; R:114-214CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2IG2H:120-231DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L-KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)
2JB5H:121-222FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6B:121-221; H:121-221FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2JIXD:117-217; F:117-217; H:117-217CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2NXYD:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZD:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0D:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1D:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2D:3129-3228HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3D:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4D:3129-3229HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5H:3129-3228HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY6D:3129-3228HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY7H:114-230HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
2NYYD:119-218CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2NZ9D:119-218; F:119-218CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2OQJB:114-228; E:114-228; H:114-228; K:114-228CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2P8LB:114-213CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
2P8MB:114-213CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
2P8PB:114-214CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
2PR4H:133-232CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
2PW1B:114-214CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
2PW2B:114-214CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
2QADD:114-214; H:114-214STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
2QQNH:114-216NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2QR0B:114-216; F:114-216; H:114-216; L:114-216; N:114-216; R:114-216; T:114-216; X:114-216STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2R0KH:114-212PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2RCJA:120-218; B:120-218; E:120-218; F:120-218; I:120-218; J:120-218; M:120-218; N:120-218; Q:120-218; R:120-218; U:3-104SOLUTION STRUCTURE OF HUMAN IMMUNOGLOBULIN M
2RCSH:115-216IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2ZKHH:117-216HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
3B2UC:122-221; F:122-221; H:122-221; J:122-221; N:122-221; Q:122-221; T:122-221; W:122-221CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3B2VH:122-221CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3BKYH:123-226CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
3BN9D:114-214; F:114-214CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3C08H:122-223CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3C09C:122-218; H:122-218CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3C2AH:114-227; I:114-227ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
3CFJB:114-228; D:114-228; F:114-228; H:114-228CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM
3CFKB:114-228; D:114-228; F:114-228; H:114-228; I:114-228; K:114-228; N:114-228; P:114-228CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM
3DGGB:120-219; D:120-219CRYSTAL STRUCTURE OF FABOX108
3DIFB:120-218; D:120-218CRYSTAL STRUCTURE OF FABOX117
3DVGB:121-221CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI-UBIQUITIN
3DVNB:121-221; H:121-221CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI-UBIQUITIN
3EYVB:120-222; H:120-219ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3FCTB:115-216; D:115-216MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3LEVH:114-218HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
4DVRH:120-219CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD-557
4M1DH:114-213; I:114-213CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
7FABH:117-217CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
8FABB:122-223; D:122-222CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
(-)
Mouse (Mus musculus) [TaxId: 10090] (414)
12E8H:115-214; P:115-2142E8 FAB FRAGMENT
15C8H:114-226CATALYTIC ANTIBODY 5C8, FREE FAB
1A0QH:115-21129G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
1A3LH:114-227CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS-ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
1A3RH:120-228FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
1A5FH:121-217FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
1A6TB:114-213; D:114-213FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
1ACYH:113-226CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1
1AE6H:115-211IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
1AFVH:121-220; K:121-220HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1AHWB:118-214; E:118-214A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1AI1H:113-226HIV-1 V3 LOOP MIMIC
1AIFB:122-218; H:122-218ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1AXTH:114-228IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
1AY1H:116-209ANTI TAQ FAB TP7
1BAFH:116-2172.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
1BBDH:120-218THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
1BGXH:116-209TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB
1BLNB:114-227; D:114-227ANTI-P-GLYCOPROTEIN FAB MRK-16
1BM3H:126-227IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX
1BOGB:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE
1BQLH:117-215STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
1C12B:414-513INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
1C1EH:120-228CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1CBVH:123-219AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1CF8H:114-215CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
1CFNB:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE
1CFQB:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41
1CFSB:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE
1CFTB:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE
1CGSH:118-214LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
1CICB:118-217; D:117-218IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1CK0H:107-216ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM
1CL7H:114-128,I:ANTI HIV1 PROTEASE FAB
1CLOH:114-214ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
1CR9H:111-213CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
1CT8B:114-215; D:114-215CATALYTIC ANTIBODY 7C8 COMPLEX
1CU4H:111-213CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
1DBAH:113-228THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBBH:113-228THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX
1DBJH:113-228MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBKH:113-228MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DBMH:113-228MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1DQDH:123-222CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
1DQJB:114-221CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1DQMH:114-221CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY
1DQQB:114-221; D:114-221CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
1E4WH:111-209CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1E4XH:111-212; I:111-213CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1E6JH:121-219CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
1E6OH:121-219CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
1EAPB:125-221CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
1EGJH:114-225DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
1EHLH:114-22764M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
1EJOH:2620-2719FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
1EMTH:117-216FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
1EO8H:114-212INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1ETZB:127-228; H:127-228THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
1F11B:114-227; D:114-227F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
1F3DH:122-223; K:122-221CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
1F4WH:118-216CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4XH:118-216CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F4YH:118-216CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
1F58H:114-230IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
1F8TH:114-230FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE
1F90H:114-230FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
1FAIH:124-221THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
1FBIH:122-221; Q:122-221CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
1FDLH:117-218CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5-ANGSTROMS RESOLUTION
1FE8H:116-216; I:116-216; J:116-216CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
1FGNH:118-214MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
1FH5H:121-215CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33
1FIGH:114-223ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
1FJ1B:115-213; D:115-213LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
1FL3A:117-214; H:117-214CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K
1FLRH:119-2184-4-20 FAB FRAGMENT
1FNSH:337-439CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
1FORH:121-219STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
1FPTH:114-228THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
1FRGH:337-437CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
1FSKC:119-220; F:119-220; I:119-220; L:119-220COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
1GGBH:113-228MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGCH:113-228MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGIH:113-228; J:113-228CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
1GHFH:116-213ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
1GIGH:121-221REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1, LAMBDA ANTIBODY
1GPOH:114-214; I:114-212CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
1H0DB:114-215CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
1H3PH:114-216STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
1HH6B:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HH9B:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HI6B:113-213ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE
1HILB:113-228; D:113-228STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
1HIML:113-228; M:113-228STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1HINH:113-228STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
1HQ4B:114-213; D:114-213STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
1HYSD:124-220CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
1I8MB:114-213; H:114-213CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
1I9IH:119-220NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1I9JH:119-220TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
1IAIH:122-219; I:122-218IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1IBGH:114-223STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
1IFHH:113-228A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES
1IGCH:120-222IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
1IGFH:114-227; J:114-227CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
1IGIH:115-22726-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1IGJB:115-227; D:115-22726-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1IGTB:115-235; D:115-235STRUCTURE OF IMMUNOGLOBULIN
1IGYB:114-235; D:114-235STRUCTURE OF IMMUNOGLOBULIN
1IKFH:127-228A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
1IL1A:122-221CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY
1INDH:115-213HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1INEH:115-213HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE
1IQWH:122-221CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS ANTIBODY HFE7A
1J5OH:124-220CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER
1JFQH:422-521ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71"
1JGLH:114-213CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
1JGUH:114-212STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JGVH:114-213STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JHKH:114-213CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2
1JN6B:121-217CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNHB:121-217; D:121-217; F:121-217; H:121-217CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNLH:115-231CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNNH:115-229CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JRHH:114-221COMPLEX (ANTIBODY/ANTIGEN)
1K4CA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1K4DA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1K6QH:118-216CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
1KB5H:114-213MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KC5H:117-217CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE
1KCRH:117-218CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
1KCSH:117-217CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1KCUH:117-217CRYSTAL STRUCTURE OF ANTIBODY PC287
1KCVH:117-217CRYSTAL STRUCTURE OF ANTIBODY PC282
1KEGH:114-228ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
1KELH:116-218CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
1KEMH:116-218CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
1KENH:121-221; T:121-219INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
1KFAH:127-227; I:127-225CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
1KN2H:114-223CATALYTIC ANTIBODY D2.3 COMPLEX
1KN4H:114-223CATALYTIC ANTIBODY D2.3 COMPLEX
1KNOB:120-235; D:120-235; F:120-235CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
1L7TH:119-220CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
1LO0H:120-221; Y:120-221CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
1LO2H:120-221; Y:120-221RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
1LO3H:120-221; Y:120-221RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
1LO4H:119-220RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
1MAMH:120-217CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
1MEXH:114-226ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
1MF2H:114-209; N:114-209ANTI HIV1 PROTEASE FAB COMPLEX
1MFBH:368-468HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFCH:368-468HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
1MFDH:368-468THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
1MFEH:368-468RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT
1MH5B:114-193; H:114-214THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
1MHHB:114-212; D:114-212ANTIBODY-ANTIGEN COMPLEX
1MIEH:114-228CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
1MJ7H:114-228CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
1MJ8H:114-231HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
1MJJB:114-228; H:114-227HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION-STATE ANALOG
1MJUH:114-2301.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
1MLBB:119-218MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
1MLCB:119-218; D:119-218MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME
1MNUH:122-222UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MPAH:122-225BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1MRCH:116-227PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRDH:116-227PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MREH:116-227PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1MRFH:116-227PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
1N5YH:124-225HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1N64H:114-213CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
1N6QH:124-225HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1NAKH:114-229; I:114-229IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
1NBVH:123-219AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
1NBYB:414-510CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
1NBZB:414-510CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
1NC2B:121-219; D:121-221CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y-DOTA
1NC4B:121-219; D:121-220CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD-DOTA
1NCAH:114-227REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NCBH:114-227CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCCH:114-227CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1NCDH:114-227REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1NCWH:114-231CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
1ND0B:114-231; D:114-231; F:114-231; H:114-231CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
1NDGB:414-521CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME
1NDMB:414-521CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
1NGPH:121-220N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3-NITROPHENYL) ACETATE
1NGQH:121-220N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1NJ9B:114-212; H:114-212COCAINE HYDROLYTIC ANTIBODY 15A10
1NLBH:114-213CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
1NLDH:113-215FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
1NSNH:115-223THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
1OAKH:337-437CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
1OB1B:114-212; E:114-212CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1OPGH:126-227OPG2 FAB FRAGMENT
1ORQB:119-219X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
1ORSB:119-221X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
1OSPH:121-218CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
1OTSC:122-222; E:122-222STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
1OTTC:122-222; E:122-222STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
1OTUC:122-222; E:122-222STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
1P2CB:414-516; E:1314-1417CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
1P7KB:114-214; H:114-215CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
1PG7X:114-213; Z:114-213MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
1PLGH:118-215EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)-POLYSIALIC ACID
1PSKH:115-209THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
1Q0XH:114-228ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
1Q0YH:114-228ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
1Q72H:114-228ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1Q9KB:112-211S25-2 FAB UNLIGANDED 1
1Q9LB:112-211; D:112-211S25-2 FAB UNLIGANDED 2
1Q9OB:112-213; D:112-213S45-18 FAB UNLIGANDED
1Q9WB:112-213; D:112-213S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
1QBLH:113-219FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
1QBMH:113-219FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
1QFUH:114-214INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1QKZH:114-213FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G
1QYGH:114-228ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
1R0AH:124-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1R3IH:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1R3JB:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1R3KB:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1R3LB:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1RFDH:114-228ANTI-COCAINE ANTIBODY M82G2
1RIHH:114-215CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
1RIUH:114-228ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
1RIVH:114-228ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META-OXYBENZOYLECGONINE
1RJLB:121-221STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1RMFH:120-216STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1RU9H:114-231CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
1RUAH:114-231CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUKH:114-231CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
1RULH:114-231CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
1RUMH:114-231CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1RUPH:114-231CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
1RUQH:114-227CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
1RURH:114-227CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
1S5HB:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1S5IH:114-230FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE
1SBSH:124-222CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
1SM3H:114-213CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE
1SY6H:120-219CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
1T03H:124-225HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
1T2QH:120-220THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
1T4KB:114-228; D:114-228CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
1T66D:119-220; H:119-220THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
1TETH:113-213CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
1TPXB:114-223; C:108-214OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
1TQBB:114-223; C:108-214OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
1TQCB:114-223; C:108-214OVINE RECOMBINANT PRP(114-234), ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
1UB5A:117-214; H:117-214CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
1UB6A:117-214; H:117-214CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND
1UWXH:115-215; M:115-215P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
1UYWH:115-213; M:115-213CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
1V7MH:117-217; I:117-217HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1V7NH:117-217; I:117-217; J:117-217; K:117-217HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1VPOH:119-221CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
1WC7B:114-211; H:114-214FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBB:114-214; H:114-213PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1WEJH:113-223IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
1XGYH:114-214; I:114-214CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42-41L
1YECH:114-223STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)
1YEDB:116-217; H:116-217STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
1YEEH:114-223STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)
1YEFH:114-223STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE
1YEGH:114-223STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT
1YEHH:114-223STRUCTURE OF IGG2A FAB FRAGMENT
1YEIH:114-223CATALYTIC ANTIBODY D2.3 COMPLEX
1YEJH:114-223CATALYTIC ANTIBODY COMPLEX
1YEKH:114-223CATALYTIC ANTIBODY D2.3 COMPLEX
1YJDH:121-218CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
1YMHB:114-213; D:114-213ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
1YNTB:619-718; D:1619-1718STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1YQVH:114-224THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
1YUHB:119-218; H:119-218FAB FRAGMENT
1Z3GH:116-216; I:116-216CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
1ZTXH:114-228WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
1ZWIA:119-219STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
25C8H:114-226CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX
2A1WH:124-225; I:124-225ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I
2A6DB:111-219; H:111-219CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
2A6IB:111-219CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL
2A6JB:111-219; H:111-219CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65
2A6KB:111-219; H:111-219CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
2A77H:123-223ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II
2AABH:114-214STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM
2ADFH:119-218CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
2ADGB:114-213CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
2ADIB:114-213CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
2ADJB:114-213CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
2AEPH:114-190AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2AI0H:124-224; I:124-223; J:124-223; K:124-223ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III
2ATKA:119-219STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2BDNH:118-217CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY, 11K2
2BMKB:114-214; H:114-214FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2BOBA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2BRRH:115-214; Y:115-214COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2CGRH:118-214LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
2CK0H:107-216ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
2D03H:120-220CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
2DBLH:113-228MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2DDQH:115-213CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
2DQTH:114-215HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DQUH:114-215CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DTG  [entry was replaced by entry 4ZXB without any SCOP domain information]
2DTMH:114-215THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
2DWDA:119-219CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2DWEA:119-219CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2F19H:124-221THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2F58H:114-230IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
2FATH:114-208AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2FD6H:114-208STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
2G60H:103-224STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
2GFBB:120-227; D:120-227; F:120-227; H:120-227; J:120-227; L:120-227; N:120-227; P:120-227CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY
2GSIB:115-228; D:115-228; F:115-228; H:115-228CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2H1PH:421-520THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
2HJFA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2HMID:124-220HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
2HRPH:114-214; N:114-212ANTIGEN-ANTIBODY COMPLEX
2HVJA:119-219CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2HVKA:119-219CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2IFFH:117-215STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
2IGFH:114-233CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2IH1A:119-219ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2IH3A:119-219ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2ITDA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2J4WH:113-233STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J5LC:113-233STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J88H:113-180HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT
2JELH:114-226JEL42 FAB/HPR COMPLEX
2JK5A:119-219POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2MPAH:122-224BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
2NLJB:119-218POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2NR6D:117-213; F:117-213CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2OJZH:114-228; I:114-228ANTI-DNA ANTIBODY ED10
2OK0H:114-228FAB ED10-DNA COMPLEX
2OR9H:114-212; I:114-212THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
2ORBH:114-212; I:114-212THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
2OZ4H:115-214STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2P7TA:119-219CRYSTAL STRUCTURE OF KCSA MUTANT
2PCPB:114-226; D:114-226ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2Q76B:117-216; D:117-216MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
2Q8AH:113-208STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2Q8BH:113-210STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2QHRH:115-212CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
2R0WH:115-213PFA2 FAB COMPLEXED WITH ABETA1-8
2R1WB:112-211CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1XB:112-210CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R1YB:112-211CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R23B:112-213CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2BB:112-210CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2EB:112-210CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2R2HB:112-211STRUCTURE OF S25-2 IN COMPLEX WITH KO
2UYLB:120-219; N:120-219; W:120-219; Y:120-219CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2V7HB:111-219; H:111-219CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2VC2H:121-221RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2VDKH:121-221RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDLH:121-221RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDMH:121-221RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
2VDNH:121-221RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
2VDOH:121-221INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV
2VDPH:121-221INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV
2VDQH:121-221INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV
2VDRH:121-221INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV
2VIRB:121-221INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VISB:121-221INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VITB:121-221INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY
2VL5A:121-218; C:121-218STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2W0FA:119-218POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2Z4QB:119-185CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2Z91A:114-212; C:114-212CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2Z92A:114-212CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2Z93A:116-212; C:114-212CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD
2ZJSH:120-220CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
32C2B:120-218STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
35C8H:114-226CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX
3BAEH:114-180CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
3BKCH:114-180CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB)
3BKJH:114-180CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
3BKMH:114-180STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121)
3BPCB:112-210CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4-EPI-2,3-DEHYDRO KDO (4.8) KDO
3BQUD:123-192CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BT2H:114-208STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3CK0H:107-216ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II
3CLEH:114-188HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CLFH:114-188HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CMOH:115-223; Y:115-223HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3CVHH:121-219; Q:121-219HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CVIH:121-219HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3F58H:114-230IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
3FB5A:119-219KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
3FO9B:114-228; H:114-228CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3GB7A:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3HFMH:114-215STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
3IGAA:119-219POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3OR6A:119-219ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3OR7A:119-219ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
3STLA:119-219KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3STZA:119-219KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
3SY0B:112-211S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
3T4YB:112-211S25-2- KDO MONOSACCHARIDE COMPLEX
3T65B:112-211S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3T77B:112-213S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
4ENEC:122-222; E:122-222STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
4FABH:119-216THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-2,4-PENTANEDIOL
4HGWB:113-211CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 5,6-DEHYDRO-KDO DISACCHARIDE
4KJQC:122-222; E:122-222STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KK8C:122-222; E:122-222STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4KKLC:122-222; E:122-222STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4LBEA:119-219STRUCTURE OF KCSA WITH R122A MUTATION
4LCUA:119-219STRUCTURE OF KCSA WITH E118A MUTATION
4LOUC:122-222; E:122-222STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4MSWA:119-219Y78 ESTER MUTANT OF KCSA IN HIGH K+
6FABH:122-222THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P-AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN
(-)
Mouse (Mus musculus), gamma3 [TaxId: 10090] (8)
1CLZH:115-231IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1M71B:114-213CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
1M7DB:114-213CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
1M7IB:114-213CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
1PZ5B:114-213STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
1R24B:123-217; D:123-217FAB FROM MURINE IGG3 KAPPA
1UZ6F:114-212; H:114-212; P:114-212; W:114-212ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
1UZ8B:114-212; H:114-212ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (5)
1BFOB:122-216; D:122-216; F:122-216; H:122-216CAMPATH-1G IGG2B RAT MONOCLONAL FAB
1C5DB:118-215; H:118-214THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
1FN4B:107-208; D:107-208CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
1LK3H:120-219; I:120-219ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
2ARJB:114-228; H:114-228CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
(-)
Synthetic construct [TaxId: 32630] (1)
2R0LH:114-212SHORT FORM HGFA WITH INHIBITORY FAB75
(-)
Protein domain: Immunoglobulin heavy chain gamma constant domain 2, CH2-gamma (36)
(-)
Human (Homo sapiens) [TaxId: 9606] (31)
1ADQA:238-341CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
1DN2A:237-341; B:237-341FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
1E4KA:229-341; B:229-341CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
1FC1A:238-341; B:238-341CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1FC2D:238-341CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1FCCA:238-341; B:238-341CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
1H3TA:238-341; B:238-341CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2
1H3UA:238-341; B:238-341CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2
1H3VA:238-341; B:238-341CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121
1H3WM:238-341STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY
1H3XA:238-341; B:238-341CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2
1H3YA:238-341; B:238-341CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION
1HZHH:236-359; K:239-359CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1L6XA:237-341FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1MCOH:220-327THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
1OQOA:237-341; B:236-341COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
1OQXA:236-341; B:236-341G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
1T83A:235-341; B:235-341CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1T89A:235-341; B:235-341CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
2DTSA:234-341; B:237-341CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
2GJ7A:237-339; B:237-339CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
2IWGA:237-341; D:237-341COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2QL1A:236-339STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT
3AVEA:234-341; B:237-341CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
3AY4A:229-341; B:229-341CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
3D6GA:236-339; B:236-339FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.
3DJ9A:CRYSTAL STRUCTURE OF AN ISOLATED, UNGLYCOSYLATED ANTIBODY CH2 DOMAIN
3SGJA:226-341; B:227-341UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
3SGKA:236-341; B:232-341UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE
3V95A:236-341; B:237-341CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
4DZ8A:236-339; B:239-339HUMAN IGG1 FC FRAGMENT HETERODIMER
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1IGYB:236-361; D:236-361STRUCTURE OF IMMUNOGLOBULIN
(-)
Mouse (Mus musculus), gamma2 [TaxId: 10090] (1)
1IGTB:236-361; D:236-361STRUCTURE OF IMMUNOGLOBULIN
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (3)
1FRTC:239-341CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1I1AC:239-341; D:239-341CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1I1CA:239-341; B:239-341NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
(-)
Protein domain: Immunoglobulin heavy chain gamma constant domain 3, CH3-gamma (38)
(-)
Guinea pig (Cavia porcellus) [TaxId: 10141] (1)
1PFCA:MOLECULAR-REPLACEMENT STRUCTURE OF GUINEA PIG IGG1 P*FC(PRIME) REFINED AT 3.1 ANGSTROMS RESOLUTION
(-)
Human (Homo sapiens) [TaxId: 9606] (31)
1ADQA:342-443CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
1DN2A:342-443; B:342-443FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
1E4KA:342-444; B:342-444CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
1FC1A:342-444; B:342-444CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1FC2D:342-444CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1FCCA:342-443; B:342-443CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
1H3TA:342-445; B:342-444CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2
1H3UA:342-445; B:342-444CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2
1H3VA:342-445; B:342-444CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121
1H3WM:342-443STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY
1H3XA:342-445; B:342-444CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2
1H3YA:342-443; B:342-443CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION
1HZHH:360-478; K:360-475CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1L6XA:342-443FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1MCOH:328-428THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION
1OQOA:342-444; B:342-443COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z
1OQXA:342-445; B:342-444G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
1T83A:342-443; B:342-443CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1T89A:342-443; B:342-443CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
1ZA6B:239-344; D:239-344; F:239-344; H:239-344THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2DTSA:342-444; B:342-444CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
2GJ7A:340-443; B:340-443CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
2IWGA:342-443; D:342-443COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2QL1A:340-444STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT
3AVEA:342-444; B:342-444CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
3AY4A:342-443; B:342-444CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR II